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ABSTRACT 
Rationale 
Indoor residual spraying (IRS), using lambda-cyhalothrin, was piloted in 
Malawi in 2007 by the Presidents Malaria Initiative (PMI) in Nkhota-kota 
district. The Ministry of Health scaled up IRS to six additional districts 
across Malawi including Chikhwawa, in 2011. This study was designed to 
assess the impact of IRS against a background of high malaria prevalence 
and possible insecticide resistance on the major malaria vectors of 
Malawi, Anopheles gambiae and An. funestus in Chikhwawa; and to 
measure the impact of IRS on entomological indices and malaria 
prevalence in children of under 5 years of age. 
Methodology 
Three sentinel sites (Mwingama, Namila and Tsekera) were established in 
Chikhwawa and 6 window exit traps installed at each site. IRS was 
conducted in February 2011. Mosquitoes were captured daily, from 
October 2010 to April 2012, and analysed for species abundance and 
sporozoites. Separate mosquito collections were carried out using 
standard WHO insecticide susceptibility assays on An. gambiae and An. 
funestus from the sentinel sites.  Insecticide quantification of IRS was 
determined by colorimetric analysis of the wall pads placed on selected 
houses within the sentinel sites. Anaemia and parasitaemia were 
determined in children of less than 5 years old from a 50 villages 
catchment area including the three sentinel sites, through rolling malaria 
indicator surveys (rMIS). 
 
Results and Conclusion 
The study has shown large heterogeneity in mosquito abundance 
between sentinel sites. Suspected cross resistance found was found in 
both An. gambiae and An. funestus to carbamates, organophosphates 
and pyrethroids suggesting a metabolic based resistance mechanism. 
Clear resistance (77% mortality) was only found at Namila to 
deltamethrin in An. funestus. There was significant change in resistance 
pattern at Namila in An. funestus to lambda-cyhalothrin between 2011 
and 2012 (X2 = 6.011, p = 0.014).  
No statistically significant change was observed in An. gambiae and An. 
funestus abundance differences pre-post IRS suggesting programmatic 
IRS challenges in Chikhwawa. There was a decline on parasitaemia 
prevalence from an average of 41% to 29% post IRS. 
While entomological surveillance is important for the vector control 
programme in Malawi, there is a need to utilise this data to improve the 
actual IRS activities, especially when combined with the results of malaria 
burden as seen here. 
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2. INTRODUCTION 
Malaria is the most important of the parasitic diseases of humans with 
approximately 70% of the population resides in areas infested with 
potential malaria vectors [1, 2]. The World Health Organisation ranked 
malaria as the eighth-highest contributor to the global disease burden 
and the second highest in Africa [3]. Recent estimates of malaria deaths 
have varied from 0.5 to 3.0 million per year [2, 4, 5] and of 10.6 million 
yearly deaths in children under 5 years, 8 percent are ascribed to malaria 
[6]. Malaria control efforts have been intensified in recent years in order 
to meet Roll Back Malaria, World Health Assembly and Millennium 
Development targets of universal access and coverage, that aim to 
prevent, reduce or eliminate disease transmission [7]. The success of 
these increased control efforts can be seen in the number of countries 
that have recorded decreases in the number of confirmed cases of 
malaria and/ or reported reduced admission and deaths since 2000 [2].  
 
In Malawi malaria is endemic and the transmission rates are intense, with 
seasonal and geographical heterogeneity [8]. Plasmodium falciparum 
malaria is one of the most important public health problems in Malawi, 
where it is estimated to cause 18.5% of hospital deaths among children 
<5 years old and one third of all the outpatient visits.  
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Current strategies to reduce malaria transmission rely heavily on vector 
control, specifically the use of insecticide treated bed nets (ITNs), indoor 
residual spraying (IRS), and source reduction [9]. In Malawi, a pilot IRS 
programme, using lambda-cyhalothrin, was initiated in 2007 in 
Nkhotakota district, central Malawi, under the President’s Malaria 
Initiative (PMI). This was later scaled up in 2010 by the National Malaria 
Control Programme to include the six high malaria endemic districts, 
Chikhwawa, Karonga, Mangochi, Nkhata-bay, Nsanje and Salima districts. 
In the fight against malaria and the push toward control, elimination and 
eradication, interventions must be effectively used and accurately 
evaluated. Insecticide-based malaria vector control is known to result in 
increasing resistance among the malaria vectors because of the selection 
pressure placed on the resistance genes [1]. Entomological surveillance to 
assess the impact of control interventions and monitoring are essential 
components of any insecticide based malaria vector control programme.  
 
The objectives of this study are; 
 
1. to assess the insecticide resistance status of Anopheles gambiae 
and Anopheles funestus the predominant malaria vectors in  
Chikhwawa 
2. to generate a base line of entomological indicators including 
vector abundance and transmission to monitor by which to 
measure the impact of vector control 
14 
3. to correlate the entomological indices with malaria 
parasitaemia prevalence before and after vector control 
 
The study was developed within a programmatic setting where the 
intervention was delivered by the ministry of health (MoH) throughout 
the district, leaving no option for a contemporaneous control arm. I 
assumed that there would be a reduction in malaria vector abundance 
and a corresponding decline in parasitaemia and anaemia prevalence as a 
result of IRS in Chikhwawa.  
 
The author of this thesis did and supervised all the entomological 
fieldwork, laboratory preparation of the mosquitoes and insectary 
bioassays.  Mavuto Mukaka, a Malawi-Liverpool Wellcome Trust (MLW) 
biostatistician, supervised data analysis. Molecular analysis of the 
mosquito samples to species level, sporozoite detection and wall pad 
bioassays was done by Miss Kay Hemmings under the supervision of Dr. 
Mark Paine and Dr. Michael Coleman, from the vector group at Liverpool 
School of Tropical Medicine. Parasitaemia and anaemia data was 
provided by Dr. Anja Terlouw, as part of monitoring and evaluation 
Surveys conducted under the umbrella of the Artemisinin Combination 
Therapy in Action (ACTia) drug trial within Malawi Liverpool Wellcome 
Trust in Chikhwawa.  
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3. LITERATURE REVIEW 
3.1. The Global Burden of Malaria 
Malaria is a complex and deadly disease that puts approximately 3.3 
billion people at risk in 109 countries and territories around the world 
[2]. Malaria exacts its greatest toll in sub-Saharan Africa countries where 
approximately 70% of the population resides in areas infested with 
potential malaria vectors [10]. Approximately 80% of cases and 90% of 
deaths are estimated occur in the WHO African Region, with children 
under five years of age and pregnant women most severely affected [2]. 
Other high risk groups include adolescents [11] non-immune travellers, 
refugees, displaced persons and labourers from non-endemic areas 
entering the endemic areas [12].  According to WHO 2012 malaria report, 
50 countries are on track to reduce their malaria case incidence rates by 
75%, in line with the World Health Assembly and Roll Back Malaria 
targets for 2015 [2]. However, these 50 countries account for only 3% (or 
7 million) of the total estimated malaria cases worldwide. International 
targets for malaria will be attained if considerable progress is made in 
the 14 highest burden countries, which account for an estimated 80% of 
malaria deaths. By 2005, the estimates of global falciparum malaria 
morbidity burden had increased to 515 million cases, with Africa 
suffering the vast majority of this toll [13]. Contributing to this 
resurgence were the increasing problems of Plasmodium falciparum 
resistance to drugs and of the Anopheles vector’s resistance to 
insecticides [14]. The economic burden due to malaria, in Africa alone, is 
unprecedented, contributing to the cycle of poverty and limiting 
economic development [15]. For example, Africa alone is estimated to 
lose at least US$12 billion per year in direct losses (e.g. illness, treatment, 
premature death), and many times more than that in lost economic 
growth [1]. 
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Control of malaria is currently on the political agenda of several of the 
world’s wealthiest countries and funds have become available from the 
Global Fund for Aids, Tuberculosis and Malaria, The US Presidents 
Malaria Initiative, the World Bank and other bilateral donors to combat 
malaria, on a scale not seen since the first attempted malaria eradication 
campaign in the 1950s and 1960 [16]. This substantial increase in funding 
for malaria control, with effective means for prevention and treatment, is 
associated with a decline in malaria burden [2]. 
 
Some countries have shown impressive gains following expanded vector 
control and case management. Malaria cases and deaths in health 
facilities in Rwanda declined by more than 50% between the years 2005 
and 2007 in both inpatient and outpatient slide-confirmed cases [17]. 
Similarly, in Eritrea, between 1998 and 2004, there was substantial 
reduction in routinely reported clinical malaria cases following scale-up of 
control measures [18, 19]. Compelling evidence of dramatic decline in 
malaria transmission has also been reported in Zambia [20-22]; Sao Tome 
& Principe [23] and  Zanzibar (United Republic of Tanzania)[24]. 
3.2. Malaria Status, Vectors and Control Interventions in Malawi 
3.2.1. Malaria in Malawi 
Malaria is endemic throughout Malawi and continues to be a major 
public health problem, with an estimated six million cases occurring 
annually. The most prevalent parasite species causing malaria in Malawi 
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is P. falciparum [25]. Two thirds of Malawi’s total population, of 14 
million persons, are at risk from malaria [26, 27]. This disease accounts 
for 40% of all hospitalization and 18% of hospital deaths of children less 
than five years old and 34% of all outpatient visits across all ages [27]. 
 
Malaria transmission in many parts of Malawi is seasonal as vector 
abundance increases with rainfall and temperature. The peak of 
transmission occurs in the rainy season between November to April 
especially in low-lying areas with high temperatures. In low-lying areas 
around Lake Malawi, and the Shire Valley, malaria transmission is intense 
all year.  
 
3.3. Malaria Control Interventions in Malawi 
The major malaria control intervention efforts in Malawi include; case-
management and intermittent preventative treatment (IPTs). 
 
3.3.1.1. Chemotherapy 
For many years the treatment of malaria in Malawi relied on chloroquine, 
sulfadoxine combined with pyrimethamine (SP), and quinine, with the 
latter being used mainly to treat severe cases. In 1993 Malawi became 
the first African country to change its first line antimalarial drug from 
chloroquine to sulfadoxine-pyrimethamine on a nationwide basis in the 
face of rising rates of resistance to chloroquine [28, 29]. Over the past 5 
years artemisinin-based combination therapy (ACTs) have been 
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introduced. Artemether-lumefantrine (called LA in-country) became the 
first-line treatment of uncomplicated malaria in 2008 due to resistance 
concerns in sulfadoxine-pyrimethamine [30, 31].  By 2009, all 42 African 
malaria endemic countries had changed their policies to support ACT use 
for uncomplicated malaria [32]. More recently countries have started to 
adopt policies promoting confirmed malaria diagnosis using malaria 
microscopy and / or rapid diagnostic tests (RDTs), and Malawi has 
introduced the use of RDTs in 2012. 
 
3.3.1.2. Intermittent Presumptive Treatment (IPT) 
Intermittent Presumptive Treatment for malaria in pregnant women 
(IPTp) is a WHO recommended measure to prevent the consequences of 
gestational malaria [33, 34]. Intermittent preventive therapy was 
evaluated for the first time in Malawi in mid 1990’s [35]. Clinical trials 
have confirmed that IPT reduces the incidence of the major 
complications of gestational malaria, namely anaemia in the mother and 
low birth weight in the baby and also reduce rates of re-admittance to 
hospital for severe anaemia or malaria in children [36]. Intermittent 
presumptive treatment (IPT) involves the administration of a curative 
dose of an antimalarial drug at predefined intervals to a subject living in 
an endemic area, without determining whether that subject is parasitic 
[37]. Malawi IPTp programme has achieved reasonable coverage, but 
there are increasing concerns about the effectiveness of SP due to the 
documented spread of drug resistance. 
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3.3.2. Insecticide Treated Nets 
While ITNs are often seen as a personal protection measure they can also 
decrease local malaria transmission by mass killing and decreased 
survival of Anopheline vectors, thereby protecting those in the 
community without ITNs if coverage and usage is high [38]. Four 
randomised trials, in Africa, which had child mortality as the primary 
endpoint, found a reduction in deaths among children under 5 years of 
+age with the use of ITNs (three trials) or insecticide-treated curtains 
[39]. A more recent innovation is the long-lasting insecticide-treated net 
(LLIN), in which insecticide is either incorporated into the fibre during 
extrusion, or coated on the fibre or the finished net with a binding agent 
[40]. 
In Malawi, the current National Malaria Control Programme (NMCP) 
guidance aims for universal coverage of LLINs which is defined as one net 
per two people [41]. To achieve this, the NMCP supported a three-
pronged approach to LLIN distribution: 1) routine distribution of free 
LLINs through antenatal care (ANC) and expanded programmes on 
immunization (EPI) clinics, 2) periodic mass campaigns covering the entire 
population, and 3) traditional social marketing through private sector 
outlets. Under the routine distribution channel, the policy states that a 
pregnant woman should receive a free LLIN either during her first ANC 
visit or at childbirth if her new-born is delivered in a health facility. In 
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addition, every child less than one year old receives a free LLIN at his or 
her first EPI visit [41]. 
 
From 2007 pyrethroid-impregnated LLINs have been distributed through 
antenatal and under-5 clinics at district and central hospitals throughout 
Malawi [2]. By 2008, approximately 4 million LLINs were procured and 
approximately 2 million distributed. The percentage coverage for ITN 
increased between the years 2008 and 2010 from 37% to 42% 
respectively [2]. In 2012 (after the completion of the data collection for 
this study) a country-wide distribution campaign was held to support the 
latest WHO universal coverage targets of 1 net for every 2 individuals. 
 
3.3.2.1. Indoor Residual Spray  
IRS was included in the Malawi Malaria Strategic Plan of 2011-2015 as a 
key malaria prevention strategy [41]. It encompasses the application of 
chemical insecticides onto surfaces where mosquitoes may land and rest 
indoors in order to kill the adult vector mosquitoes [42]. Scientific 
evidence of IRS in reducing or interrupting malaria transmission in 
different epidemiological settings has been available since the 1940s and 
1950s [43-45]. Studies have shown that IRS has substantially reduced 
infant and child mortality [46]. From the year 2000, there has been an 
increase in the coverage of IRS across the African continent (Figure 3.1). 
There has been evidence of IRS disrupting malaria transmission, 
eliminating malaria vectors and reducing malaria incidence [47-49]. South 
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Africa and Swaziland are good examples of where IRS has successfully 
controlled the disease to the point that both countries are in currently in 
elimination phase [50]. More recently in Bioko, Equatorial Guinea IRS has 
successfully controlled all three major vectors that were responsible for 
malaria transmission [46, 51]. 
In the year 2007, the President’s Malaria Initiative (PMI) supported a pilot 
of IRS in Malawi, using Lambda-cyhalothrin, initially covering 27,000 
houses in the northern section of Nkhotakota district. This was expanded 
in 2008 and again in 2009 covering parts of Nkhotakota and Salima 
districts [52]. However, no indicators were measured for the success or 
failure of the programme.  Following the PMI efforts the NMCP expanded  
IRS to another five districts across Malawi, covering 500,000 houses and 
protecting an estimated 2.5 million people [41]. The districts covered 
included Chikhwawa, Karonga, Mangochi, Nkhata-bay, Nkhotakota, 
Nsanje and Salima. In 2010, the NMCP used the pyrethroid alpha-
cypermethrin, (Morkid) in its five supported districts (including 
Chikhwawa) while PMI-supported districts changed to an 
organophosphate, pirimiphos-methyl (Actelic 300cs), due to pyrethroid 
resistance in the main vector An. funestus in that area [53]. Morkid was 
not on the WHOPES list of recommended compounds for IRS. 
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Fig 3.1 Progress in vector control coverage in sub-Saharan Africa from 
2000 to 2010, Global Malaria Programme [54]. 
 
3.4. The Malaria Mosquito Vector 
The major malaria vectors in sub-Saharan Africa are An. gambiae s.s. 
Giles, An. arabiensis Patton and An. funestus Giles (Diptera: Culicidae) 
[55]. Humans become infected with malaria as a result of their exposure 
to blood-feeding infectious female Anopheles mosquitoes. Blood feeding 
is critical and obligatory in female mosquitoes as a vital source of proteins 
essential for egg development and maturation. There are a number of 
factors that contribute to the unprecedented malaria disease burden in 
Africa. This region supports the most efficient Anopheles mosquito 
vectors that transmit malaria and are difficult to control as mosquitoes 
have developed resistance to insecticides commonly used [56]. 
Anopheles gambiae and An. funestus are predominant malaria vectors in 
Malawi with An. arabiensis playing a minor role in some areas [25].  
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3.4.1. The Anopheles gambiae Complex 
The events leading to discovery of the complex An. gambiae in the early 
1960s have been well described [57]. Research has shown it to be a 
complex of at least seven morphologically indistinguishable species 
showing pronounced ecological and behaviour diversity [58-60]. These 
are An. gambiae sensu stricto and An. arabiensis both present in Malawi 
[25]. The other species of the complex include; An. melas , An. merus , 
An. bwambae, An. coluzzii and a An. amharicus [61, 62]. Three of these 
sibling species are adapted to fresh-water breeding sites: An. gambiae 
s.s, An. arabiensis and An. quadriannulatus; two are brackish water 
breeding: An. merus and An. melas and one to mineral water: An.  
bwambae [60, 63-65]. 
 
Anopheles gambiae s.s. is an efficient vector of malaria and lymphatic 
filariasis in Africa [66]. Females of this species show a high degree of 
anthropophily [64] and are therefore a major public health concern.  The 
taxonomy of An. gambiae s.s is complicated as this species seems to be in 
the process of further speciation in West Africa [67]. In West Africa, it 
exists as two distinct molecular forms, referred to as ‘M’ and ‘S’ based on 
the variation observed in molecular markers [68, 69]. “M form” is named 
An. coluzzii while the “S form” retains the nominotypical name An. 
gambiae Giles [62]. Molecular analysis of the intergenic spacer and the 
internal transcribed spacer region of rDNA, revealed nucleotide 
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substitution that differentiated two forms within An. gambiae s.s. 
designated as S and M forms in the case of IGS [68], and Types I and Type 
II in the case of ITS [70].  
 
Anopheles arabiensis is one of the most recognized malaria vectors in 
Africa [63, 71]. Even in the presence of other notorious vector species 
such as An. gambiae and An. funestus, An. arabiensis can play a major 
role, contributing a large proportion of the infectious mosquito bites that 
drive intense malaria transmission in communities throughout sub-
Saharan Africa [72-75]. This species differs dramatically from An. gambiae 
and An. funestus  because it is more zoophilic [76] and more outdoor 
resting and outdoor biting behaviours [63, 74, 77, 78]. Anopheles 
arabiensis frequently feeds on cattle, goats, chickens, dogs, and other 
available wild and domestic animals. These feeding and resting 
behaviours complicate the role of An. arabiensis in malaria transmission, 
the ease with which this role is effectively determined through traditional 
field sampling techniques, and ultimately malaria control [79]. The 
behaviour of An. arabiensis females, makes them only partially 
vulnerable to IRS [63, 80]. This could result in the maintenance of low 
malaria transmission even when the An. gambiae and An. funestus have 
been controlled using indoor vector control methods. Where, An. 
gambiae s.s. thrives and predominates in humid conditions, An. 
arabiensis is relatively successful in arid zones [81]. 
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Anopheles quadriannulatus is less widespread in its distribution and 
occurs widely in separated areas of East coast Africa [64, 82]. In Malawi, it 
has been found widely in southern region [83]. In Zanzibar and Southern 
Africa, An. quadriannulatus was almost completely exophilic while it 
tends to be endophilic at high altitudes in Ethiopia [64, 84]. This species 
feeds principally on animals rather than humans [85]. Further studies 
revealed that the Ethiopian population of An. quadriannulatus is a 
different species and is designated An. quadriannulatus B [61]. Anopheles 
quadriannulatus A is found in southern Africa and entirely zoophilic and 
therefore not regarded as a human malaria vector [61]. 
 
Anopheles merus is confined to the east coast of Africa, adjacent inland 
areas, coastal islands and at inland localities in association with salt pans 
[63, 64, 86, 87]. This species is predominantly zoophagic [64], but is 
responsible for low rate of malaria transmission [58] and efficient vector 
of filariasis transmission in Kenya [88]. Anopheles merus plays an 
unexpectedly important role in malaria transmission in coastal Tanzania 
[89]. 
 
Anopheles melas is a predominant malaria vector in West Africa [63, 64]. 
This species is known to feed readily on goats and sheep [64]. It was 
widely considered not to discriminate between man, cow, pig and goat 
[90]. This vector is partially responsible for transmission of malaria on 
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Bioko Island, Equatorial Guinea [91] however; it was reported as being 
controlled by IRS [46]. 
 
Anopheles bwambae has only been found from the Semliki forest area of 
the Uganda/Zaire border, where breeding is apparently confined to hot 
water springs formed by geothermal activity in the Rift valley [64]. This 
species is a local vector of malaria and filariasis in the Bwamba County 
only [65]. 
 
3.4.1.1. Species Identification 
Precise identification of each species has been carried out in isolation 
using distinct methods, as morphological characterisation for primary 
identification of members of the An. gambiae complex have limited value 
as it is not feasible to separate out some species this way [63, 64, 92]. 
 
Morphologically, there are two characters of salt water species, which 
are useful in separating them from the fresh water species. Firstly, the 
eggs of both An. melas and An. merus are characterised by being longer 
and broader opening on the dorsal surface than that of fresh water An. 
gambiae s.l. [93]. A much more physical method was introduced for 
identification of An. merus and An. melas based on differential response 
to saline waters, which distinguishes the first instar larvae of the three 
freshwater-breeding, from those of the saltwater-breeding forms [58]. 
The method was further extended in the laboratory to include all instars 
27 
using colonized An. merus, An. arabiensis and An. gambiae s.s. [94]. 
Cross-breeding has also been used with much success in elucidating 
cryptic species. The identification principle is based on hybrid sterility of 
site-specific hybrids [57]. This technique is not practical for the routine 
identification of field samples and was largely superseded by genetic [95-
97], electrophoretic [85] and polymerase chain reaction (PCR) based 
techniques [98, 99]. 
 
An attempt to investigate the possibility of identifying adults of both 
sexes of An. gambiae and An. arabiensis by extracting and analysing their 
cuticular hydrocarbons was done in the mid-1970s [100]. The preliminary 
results of this study merit more detailed appraisal of these non-volatile 
and chemically inert cuticular hydrocarbons for the separation of An. 
gambiae and An. arabiensis and other species within the gambiae 
complex. 
 
Bushrod successfully separated An. merus from the fresh water species of 
the An. gambiae complex, An. gambiae s.s. and An. arabiensis, in 
Tanzania by plotting the number of coeloconic sensilla against the palpal 
ratio [101]. Further studies showed that An. gambiae and An. arabiensis 
could be distinguished from An. merus and An. quadriannulatus by the 
width of the pale band at the apex of hind tarsus three and the base of 
hind tarsus four [102, 103]. An evaluation of effectiveness of this method 
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to identifying An. gambiae was carried out in KwaZulu Natal, South 
Africa, and resulted in only 56% correct identification [104]. 
 
More recently, molecular methods have been devised which use 
differences in the DNA polymorphisms to distinguish species by the 
polymerase chain reaction (PCR) [99, 105-109]. The PCR assay developed 
by Paskwitz [105] and Scott [99] is based on species-specific fixed 
differences in the ribosomal DNA (rDNA) region, which includes part of 
the 28S coding region and part of the intergenic spacer (IGS) . The 
method uses a universal (UN)21 primer that anneals to a sequence 
shared by all members of the complex, in combination with specific 
reverse primers for An. arabiensis (AR), An. gambiae (GA), An. 
quadriannulatus (QD) and An. merus (MR) that bind to unique sequences 
of each sibling species. 
 
A method involving new primers to identify the two molecular M and S 
forms within An. gambiae s.s was developed by Flavia et al [107]. Fettene 
developed a PCR to distinguish between species A and B of An. 
quadriannulatus s.l. as well other member of the An. gambiae complex 
[108]. Fanello et al. [109] proposed a new method for differential 
identification of sibling species in the An. gambiae complex, including 
simultaneous separation of M and S forms within An. gambiae s.s. This 
method is a combination of earlier protocols by Scott [99] and Flavia 
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[107]. To clarify the speciation processes ongoing within, Anopheles 
gambiae s.s. further analysis has been done on the insertion 
polymorphism of a 200 bp SINE (SINE200) within genome areas of high 
differentiation (i.e. "speciation islands"). This resulted in the 
development of a new easy-to-use PCR for analysis of genetic 
differentiation between M and S forms [110]. 
 
3.4.2. The Anopheles funestus Group 
Anopheles funestus is a major malaria vector in southern Africa [63]. It 
includes nine species: An. funestus, An. rivulorum, An. vaneedeni, An. 
leesoni, An. confuses, An. fuscivenosus, An. brucei, An. parensis, An. aruni 
[111]. Recently “An. rivulorum-like” has been added in the group based 
on molecular sequencing data [112] and in  Malawi An. funestus-like  was 
recently identified based on combined molecular, cytogenetic and cross-
mating experiments [113]. Anopheles funestus larvae thrive in grassy 
edges or shaded area of permanent and semi-permanent water bodies 
[55, 63]. It is the only member among the complex that is recognised as 
an important vector of malaria in Africa characterised by high 
anthropophilic and endophilic behaviour [63]. The other species of the 
group are mainly zoophilic and play little or no role in malaria 
transmission. Anopheles rivulorum is only a minor vector at a localised 
site in Tanzania [114]. Because of the different vectorial capacities, biting 
and resting behaviours and the close morphologic similarity of members 
of the An. funestus group, accurate identification of field-caught material 
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is critical for vector control programmes [55, 63]. All these species show 
morphological overlap at the adult stage, although some species can be 
identified on egg and larval characteristics [55, 86]. Anopheles confusus 
can only be identified morphologically at egg and larval stage among all 
the species [113]. A separate PCR to distinguish An. funestus-like has now 
been introduced [113, 115]. 
 
3.4.2.1. Species Identification 
Sibling species belonging to the An. funestus group may be difficult to 
differentiate using traditional taxonomic methods [116]. Only four 
members of this group, namely; An. brucei, An. confusus, An. lesson and 
An. rivulorum, can be identified using egg and larval morphological 
classifications [63]. PCR-SSCP assay has been developed to discriminate 
between four members of the An. funestus group namely; An. funestus, 
An. vaneedeni, An. lessoni and An. rivulorum [117]. But because the PCR 
product show no species-specific size differences when loaded on gel for 
electrophoresis, a robust PCR has been developed to identify An. funestus 
and An rivulorum using the second ribosomal DNA internal transcribed 
spacer [116]. Cytogenetic methods have also been used to identify half 
gravid female adults of two species; An. parensis and An. funestus [118]. 
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3.4.3. Distribution of the An. gambiae Complex and An. funestus 
Group in Malawi 
The first studies of malaria vectors in Malawi were carried out in 1921 
[119] in the Upper Shire River where two major species; An. funestus and 
An. gambiae s.l (referred to as An. costalis) were identified to be 
predominant. Between the years 1922 and 1924, Lamborn carried out 
collections along the southern lake shore district of Mangochi (then Fort 
Johnson) and the results confirmed earlier findings of predominance of 
the two Anopheliese species [120]. A survey conducted in 1955 on 
mosquito vector abundance in the south Malawi singled out An. funestus 
as being in abundant throughout the year and An. gambiae in the wet 
season [121]. 
 
More recently, Tambala et al confirmed the presence of these species 
and for the first time identified An. gambiae s.s and An. arabiensis in the 
south of Malawi [122]. In 2000, Donnelly & Townson carried out detailed 
studies on the population structure of An. arabiensis in Chikhwawa, 
southern Malawi [123]. In the same year, Spiers first reported the 
presence of An. merus and An. quadrianulatus in Chikhwawa [124]. An 
investigation of lymphatic filariasis in 2003, established a structured 
distribution and predominance of mosquito species in Malawi in the 
following descending order; An. funestus, followed by An. arabiensis and 
An. gambiae s.s. [125]. 
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Plasmodium falciparum sporozoites have been detected in An. gambiae 
s.s, An. arabiensis and An. funestus and all these species have been 
shown to be the vectors of Wuchereria bancrofti in Malawi [126]. The 
absence of more comprehensive malaria transmission data for Malawi 
remains a gap in our current knowledge that needs filling, particularly in 
an era when reducing transmission is increasingly recognised as an 
important component of malaria control and a necessary step toward 
eventual elimination of the infection. The interaction between malaria 
vectors and other diseases also requires further investigation. 
 
3.5. Insecticides: Classification and Modes of Action 
The World Health Organisation (WHO) has classified public health 
insecticides into four major groups, namely; carbamates, 
organochlorines, organophosphates, and pyrethroids [127]. Insecticides 
are classified according to their chemical composition, origin, 
toxicological action and their mode of penetration.  
 
3.5.1. Pyrethroids 
Pyrethroids are a major class of neurotoxin insecticides. They are 
synthetic analogues of the naturally occurring insecticidal esters of 
chrysanthemic acid (pyrethrins I) and pyrethric acid (pyrethrins II), 
originally found in the flowers of Chrysanthemum cinerafolis [128]. 
Pyrethroids are a single insecticide class recommended by WHO for large 
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scale ITNs and IRS to control malaria transmission because of their high 
efficacy, rapid rate of knockdown, strong mosquito excite-repellence, low 
mammalian toxicity and cost efficiency [129]. Full-scale commercial 
production of pyrethrins from Chrysanthemum flowers began in the mid 
19th century, the chief ingredients in the extract being pyrethrin I and II 
which are still in use today in household sprays. However, there general 
use in agriculture was limited by their low stability in air and light, and the 
cost of production. Subsequent modification of pyrethrins resulted in the 
commonly used synthetic pyrethroids namely cyfluthrin, cypermethrin, 
deltamethrin, flumethrin, lambda-cyhalothrin and permethrin [128]. The 
pyrethrin and pyrethroid insecticides affect both the peripheral and 
central nervous systems of insects. They initially stimulate nerve cells to 
produce repetitive discharges and eventually cause paralysis, an effect 
similar to, but more pronounced than that of DDT [128]. Pyrethroids also 
have an irritant effect, causing an excitorepellency response, resulting in 
hyperactivity, rapid knock-down, feeding inhibition, shorter landing times 
and undirected flight, all of which reduce the ability of vectors to bite. 
The target site of this group of insecticide is Na+ channel proteins [130]. 
Pyrethroids have shorter residual effect of between 4 to 6 months. This 
necessitates the need to spraying pyrethroids several times a year. 
Pyrethroids when used for control interventions may require two to four 
spray cycles per year, depending on the length of the transmission 
season, with important operational and financial implications for the 
programmes [131]. 
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3.5.2. Organophosphates 
Organophosphate (OP) insecticides were discovered in 1854 but their 
insecticidal properties were only recognised in 1937 [132]. The first 
organophosphorus insecticide to be developed was tetraethyl 
pyrophosphate, used as biological warfare during the Second World War 
in Germany [133]. OPs are generally divided into three groups: aliphatic, 
phenil and heterocyclic derivates. The phenil OPs are generally more 
stable than the aliphatics and most of the public health OPs belong to the 
aliphatic group. Malathion and fenitrothion are the common examples. 
The OPs act on the mosquito vector by inhibiting acetylcholinesterase, 
preventing breakdown of the neurotransmitter acetylcholine, resulting in 
neuromuscular overstimulation and death of the vector [134]. However, 
OPs generally have relatively short residual effect of between 2 to 6 
months depending on the substrate and dosage [131]. However, a new 
formulation of pirimiphos methyl (ACTELLIC 300 CS, Syngenta) has been 
shown to be a long lasting (9 months) [135] revolutionising the use of this 
group of compounds for IRS. However, new insecticides or formulations 
of existing ones come at a cost, Actellic is approximately 12 times more 
expensive then the equivalent amount of pyrethroids. 
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3.5.3. Organochlorines 
Organochlorines are insecticides that contain carbon, hydrogen and 
chlorine. They are also commonly referred to as chlorinated 
hydrocarbons, chlorinated insecticides and chlorinated synthetics. 
Organochlorines generally belong to four groups: diphenyl aliphatics, 
hexa chlorocyclohexane (HCH), cyclodienes and polychloroterpenes. The 
mode of action is to disrupt axon depolarization of the sodium channel 
[136]. Dichlorodiphenyltrichloroethane (DDT) is the best known diphenyl 
aliphatic used in IRS. It was the insecticide used predominantly in the 
WHO eradication campaigns of the 1950s [137]. At the Stockholm 
Convention on Persistent Organic Pollutants in 2001, the use of DDT was 
banned for all applications except disease control, because of its 
environmental effects when used in large volumes.  In 2006 WHO 
reasserted the value of DDT when used for IRS [127].  DDT has long been 
a cost effective insecticide due to low cost and a long residual efficacy on 
a surface of  6 to 12 months [131]. 
 
3.5.4. Carbamates 
Carbamates are organic compounds derived from carbamic acid. They 
were originally extracted from the calabar bean, which grows in West 
Africa and contain physostigmine, a methylcarbamate ester [138]. The 
first carbamate insecticide, carbaryl, was introduced in the mid 1950s.  A 
carbamate group, carbamate ester, and carbamic acids are functional 
groups that are inter-related structurally and often are interconverted 
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chemically. Carbamate insecticides kill insects by reversibly inactivating 
the enzyme acetylcholinesterase. They are generally not persistent in the 
environment. The commonly used carbamates in public health include 
propoxur and bendiocarb. Carbamates have shorter residual effect of 
between 2 to 4 months and when used for IRS, often requiring several 
rounds of spray per disease season [131]. 
 
3.6. Insecticide Resistance 
In Africa the first case of insecticide resistance, involving An. gambiae s.s 
was reported in 1967 in Burkina Faso and was attributed to the use of 
DDT against cotton pests [139].  Today insecticide resistance is a growing 
concern in many countries which requires immediate attention [140] (Fig 
3.2). Insecticide resistance occurs when an insect develops the ability to 
withstand the effects of an insecticide by becoming resistant to its toxic 
effects by means of natural selection [1] or failure to achieve the 
expected level of control when used according to the label 
recommendation for that pest species [141]. The 21st Century has 
witnessed a pronounced increase in the use of insecticides for malaria 
control. Several major donors have invested heavily in long lasting ITNs 
and IRS activities [137, 142-145]. Currently twelve insecticides are 
approved by the WHO for IRS, but these belong to just four chemical 
classes (OPs, organochlorides, carbamates and pyrethroid) and only one 
class, pyrethroids, is recommended for the treatment of ITNs [146]. 
These same insecticide classes are also widely used to control agricultural 
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pests in Africa and this has posed an additional selection pressure on 
mosquitoes when insecticide contaminated ground water permeates 
their larval habitats. The intensive exposure to insecticides has resulted in 
the evolution of insecticide resistance in the Anopheles mosquito and 
other disease vectors [140]. 
 
Although resistance is being reported to all classes of insecticides, most 
new reports are for pyrethroids [147]. This is worrisome, as pyrethroids 
are the only insecticides that the WHO Pesticides Evaluation Scheme 
(WHOPES) approved for long lasting insecticidal bed nets and are among 
the cheapest, long-lasting insecticides for IRS; as such widespread 
mosquito resistance to pyrethroids may hinder malaria control activities.  
Trials of insecticide-treated nets with alternative insecticide classes such 
as carbamate and organophosphate have shown good efficacy [148, 
149]. However, a growing number of countries are reporting resistance to 
more than one class of insecticide, which will restrict options for 
insecticide resistance management [85]. 
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Fig 3.2 Malaria-endemic countries in Africa with reports of resistance to 
pyrethroids in at least one malaria vector in at least one monitoring site, 
2011. (Adopted from WHO Malaria Report, 2011) 
 
In 2012, WHO launched the Global Plan for insecticide Resistance 
Management (GPIRM), calling for a coordinated response to tackle the 
growing issue of insecticide resistance [1]. The plan calls on all 
stakeholders to implement a five-pillar plan: 
 Plan and implement insecticide resistance management strategies 
in malaria-endemic countries; 
 Ensure proper, timely entomological and resistance monitoring 
and effective data management; 
 Develop new, innovative vector control tools; 
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 Fill gaps in knowledge on mechanisms of insecticide resistance 
and the impact of current insecticide resistance management 
approaches; 
 And ensure that enabling mechanisms (advocacy, human and 
financial resources) are in place. 
Malawi like most effected countries has not yet carried out adequate 
insecticide resistance monitoring. This means that the global 
understanding of insecticide resistance is incomplete. 
When South Africa, changed from DDT to pyrethroids in the mid 1990s, 
we were able to observe how insecticide resistance could contribute to 
the operational failure of a control programme. In brief, An. funestus had 
been eliminated from South Africa due to the use of DDT since the 1950s, 
however the change to pyrethroids for IRS in 1996 allowed for the 
pyrethroids resistant population in Mozambique to migrate back into the 
area. Insecticide resistance of An. funestus was reported in 1999 from 
Kwazulu-Natal province [150]. This resurgence of An. funestus was 
accompanied by an increase in malaria cases and deaths [151]. The 
increase in disease burden was enhanced due to the escalation of drug 
resistance at the same time. Lessons were learnt and the malaria control 
programme (MCP) reintroduced DDT and ACTs bringing malaria under 
control again. 
 
Subsequently in 2000, An. funestus collected from Beluluane, southern 
Mozambique, were shown to also be pyrethroid resistant and that the 
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underlying mechanism was an elevated p450 [152]. As the p450 did not 
give cross resistance to DDT, this explains why South Africa was able to 
successfully swap back. Subsequent research in southern Mozambique 
showed that the insecticide resistant population of An. funestus extended 
north of the capital, Maputo [153, 154]. By 2010 An. funestus with the 
same resistance pattern was reported in northern Mozambique [155], 
which allowed for the assumption that this resistance was moving 
northwards and had entered Malawi [156]. More extensive research in 
2008/09 from 14 sentinel sites across Malawi (Fig 2.2) showed resistance 
to carbamate and pyrethroids in populations of An. funestus [157]. 
However, there was no evidence of organophosphate or DDT resistance. 
Further investigation determined that this pyrethroid/ carbamate 
resistance in An. funestus was due to the elevation of two p450’s 
CYP6P9a and CYP6P9b [157], which is the same as that found in southern 
Mozambique [158]. At this point in time it is uncertain if this resistance 
evolved de-novo in several places or spread north through Mozambique 
and into Malawi. 
 
The impact of insecticide resistance on insect borne disease programs is 
difficult to quantify [157]. Pyrethroid resistance has been selected in 
Malawi over the last 3 years in the two major malaria vectors An. 
gambiae and An. funestus, with a higher frequency in the latter. The first 
published data of insecticide resistance in An. funestus in Malawi was 
found from an island in Lake Malawi [156]. Further cases of suspected 
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pyrethroid resistance in An. funestus have been reported in some areas 
where IRS has been implemented [159]. The impact of this resistance on 
the ability of either control intervention to reduce disease transmission is 
poorly understood, and current monitoring and evaluation practices in 
Malawi are not sufficiently robust to assess this unless lack of efficacy 
occurs [157]. 
 
Elsewhere insecticide resistance monitoring has been used effectively. 
The Bioko Island Malaria Control Project, high frequencies of the L104F 
kdr allele were observed after an IRS campaign with lambda-cyhalothrin 
failed to reduce the population density of An. gambiae. However due to 
the successful control of An. funestus a modest reduction in transmission 
index and malaria reported cases was observed [46, 160]. Only after 
pyrethroids were replaced with the carbamate, bendiocarb did both 
mosquito populations decline [46]. 
 
Another programmatic study was conducted in the highland province of 
Burundi where a combination of IRS with pyrethroids and ITNs 
significantly reduced Anopheles density by 82% and transmission 
intensity by 90% despite high frequencies of the L1014S kdr allele in the 
local An. gambiae [161-163]. 
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Fig 3.3 Map of Malawi showing localisation of the different collection 
sites with insecticide resistance reports (from Wondji et al, 2012) 
 
3.6.1. Insecticide Resistance Mechanisms 
Insecticide resistance mechanisms can generally be classified as either; 
 metabolic 
 altered target site 
 behavioural and cuticular 
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Of these, altered target site and metabolic resistance are considered the 
two major mechanisms. Altered target site mechanism involves structural 
changes in the insecticide target sites thereby reducing the insecticide 
from binding. The metabolic mechanism occurs when increased or 
modified activities of an enzyme system prevent the insecticide from 
reaching its intended site of action [147]. More than one resistance 
mechanism can occur in the same vector population and one mechanism 
may give resistance to more than one insecticide group. Different types 
of resistance appear to have different capacities to reduce the 
effectiveness of insecticide based vector control interventions, with 
metabolic resistance being considered the stronger and more worrying 
mechanism [1]. 
 
3.6.1.1. Metabolic Resistance 
Metabolic resistance involves qualitative or quantitative changes in the 
enzymes, which metabolize or sequester the insecticides before they 
reach their target sites. It occurs when elevated activities of one or more 
enzymes results in a sufficient proportion of the insecticide being 
sequestered or detoxified before it reaches the target site to impair the 
toxicity of the insecticide [147]. There are generally three enzymes 
involved in this mode of action namely; esterases, glutathione S-
transferase and monooxygenases [164].  
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3.6.1.1.1. Esterases 
Esterase or carboxylesterase is a collective term for the enzymes that 
hydrolyse carboxylic esters. They comprise of six families of proteins 
belonging to the α/ß hydrolase fold superfamily [165]. Classification of 
these enzymes is difficult because of their overlapping substrate 
specificity [166]. However esterase classification of Aldridge is generally 
recognised. According to that classification, esterases inhibited by 
paraoxon in a progressive and temperature-dependent manner are called 
ß esterases and those which are not inhibited are α esterases [167]. The 
most common resistance mechanisms in insects are modified levels of 
esterase detoxification enzymes that metabolize a wide range of 
insecticides. Increased carboxylesterase activity have been associated 
with OP resistance in Culex mosquitoes, aphids, blowflies and houseflies 
[168]. 
 
3.6.1.1.2. Glutathione S-transferase 
Glutathione S-transferases (GSTs) are a major family of detoxification 
enzymes found in most organisms. All eukaryotes possess multiple GSTs 
with different substrate specificities to accommodate the wide range of 
catalytic function of this enzyme family [169]. They catalyse the 
nucleophilic attack of the endogenous tripeptide glutathione, on a variety 
of reactive substrates. In early literatures a subset of GSTs are referred to 
as DDT dehydrochlorinases (DDTases) because of their involvement in 
dehydrochlorination of DDT to DDE [170]. In mosquitoes, GSTs commonly 
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confer resistance to DDT [170]. Insect GSTs are now classified into five 
classes, but previously only two such classes were recognized [169].  In 
An. gambiae seven GSTs have been partially purified which possess 100% 
of the DDTase activity [170]. 
 
3.6.1.1.3. Monooxygenase 
Monooxygenases are a complex family of oxidative enzymes involved in 
the metabolism of xenobiotics. Monooxygenases may also be referred to 
as cytochrome P450 oxidases or mixed function oxidases (MFOs). They 
metabolize insecticides through O-, S-, and N-alkyl hydroxylation, 
aliphatic hydroxylation and epoxidation, aromatic hydroxylation, ester-
oxidation, and nitrogen and thioether oxidation [171]. Cytochrome P450s 
belong to a vast super family of enzymes. There are 62 families of P450s 
recognized in animals and plants. At least four families (4, 6, 9, and 18) of 
cytochrome P450 have been isolated from insects [172, 173]. The An. 
gambiae genome has over 90 P450s genes [173]. The insect’s P450s 
responsible for resistance primarily belong to family six, which, like 
esterase's, occur in Diptera as a cluster of genes [174]. The cytochrome 
P450 monooxygenases are involved in many cases of resistance of insects 
to insecticides primarily to pyrethroids and carbamates, and a lesser 
extent to organochlorines and organophosphates [175]. 
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3.6.1.2. Altered Target Site Resistance 
Target-site alteration prevents the insecticide interaction with the target. 
The most common form of resistance against DDT and pyrethroids, so 
called knockdown resistance (kdr), was first recognised in houseflies in 
1951 [176]. Most of these structural changes are as a result of a 
substitution of a single amino acid in the protein sequence of the target 
site. There are three major target sites for the four main insecticide 
families used in public health [177] namely; 
 acetylcholinesterase (AChE); 
 voltage gated Na+ channel proteins and 
 gamma amino butyric acid (GABA) receptor.  
In this mode of action, insecticide targets the voltage gated sodium 
channel on the insects neurone [128]. Insecticide binding delays the 
closing of the sodium channel prolonging the action potential and causing 
repetitive neuron firing, paralysis and eventual death of the insect [147]. 
 
3.6.1.2.1. Altered Acetylcholinesterase 
Acetylcholinesterase (AChE) is the target site for OPs and carbamate 
insecticides and point mutations in the Ace gene are associated with 
resistance in Drosophila melanogaster and Musca domestica [178].  
Acetylcholinesterase catalyses the hydrolysis of the neurotransmitter, 
acetylcholine, thereby ending transmission of nerve impulses at synapses 
of cholinergic neurones in central and peripheral nervous systems [179]. 
Quantitative and qualitative changes in AChE confer resistance to 
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insecticides [180]. In resistant insects the enzyme has reduced sensitivity 
to insecticide inhibition while maintaining its normal function at levels at 
least adequate for survival. Vaughan et al., demonstrated that the same 
mutations that cause insecticide resistance in D. melanogaster AChE also 
confer resistance in Aedes aegypti [181]. 
 
3.6.1.2.2. Altered GABA receptors 
The gamma amino butyric acid (GABA) receptor in insects is a gated 
chloride-ion channel in the central nervous system and in neuromuscular 
junctions [182, 183]. Altered GABA receptors are the primary target of 
pyrethroids, avermectins and cyclodiene insecticides [183-185]. All 
recorded cases of cyclodiene resistance are due to decreased sensitivity 
of the GABA subtype A receptor [186]. 
 
3.6.1.2.3. Altered sodium channel proteins 
The Na+ channel proteins in the insect nervous system are the target site 
for pyrethroids and DDT. Insects with altered Na+ channel proteins are 
resistant to the rapid knock-down effect of pyrethroids and are called 
"kdr" (knock-down resistance) or "super kdr" (highly resistant). These 
mechanisms have been observed in houseflies (M. domestica) [187, 188] 
and A. aegypti [189, 190] and many other insects. In An. gambiae s.s., kdr 
has been reported throughout West Africa [130, 191, 192] and Kenya 
[193]. It has also been reported in Zambia, the farthest south recorded to 
date [194]. This resistance is mainly associated with reduced target site 
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sensitivity arising from a single point mutation in the sodium channel 
gene, often referred to as knockdown resistance (kdr) characterised by a 
leucine-phenylalanine mutation in West Africa [130].  
 
3.6.1.3. Cuticular Resistance 
This involves modifications in the insect cuticle and/or digestive tract 
linings that prevent or slow down the absorption or penetration of 
insecticides [147]. For malaria control, where insecticides are typically 
delivered on bed nets or on wall surfaces, the uptake of insecticides is 
primarily through appendages and therefore insects have evaded this by 
an increase in the thickness of tarsal cuticle, or a reduction in its 
permeability to lipophilic insecticides. Microarray experiments have 
identified two genes cplcg3 and cplcg4, encoding cuticular proteins that 
are up regulated in pyrethroid resistant strains of Anopheles mosquitoes 
[195, 196]. To date there have been no studies on cuticular resistance in 
Malawi. 
 
3.6.1.4. Behavioural Resistance 
Behavioural resistance involves change in insect feeding or resting 
behaviour (odour repellence) to minimise contact with insecticides in the 
indoor environment as a result of intensive indoor use of insecticides. 
Studies in New Guinea and the Solomon Islands showed that the vector 
An. farauti shifted biting times from (23:00 - 03:00) to an early time of 
19:00 h after the introduction of indoor DDT before humans were 
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protected by sleeping in a sprayed room [197]. There is however 
insufficient data to assess whether these behavioural avoidance traits are 
genetic or adaptive response [198]. Genetic changes in the mosquito 
population that shifts feeding or resting behaviour could have a very 
dramatic impact on the efficacy of the current malaria vector control 
interventions, potentially exceeding the impact of physiological 
resistance [147]. To date there have been no studies of behavioural 
resistance in Malawi. 
3.7. Study Design for Entomological Impact Assessment 
There is limited information on standardised sampling guidelines for 
entomological impact assessment, unlike those for the human progress, 
coverage and impact indicators and sampling frames recommended, that 
are captured in malaria indicator surveys (MIS). Normally, villages or 
sentinel sites are selected randomly or conveniently from a pool of 
villages that represent the underlying transmission or intervention. 
Individual houses are then selected within the cluster, based on specified 
sampling criteria i.e., intervention coverage, accessibility, urbanity etc. 
This has formed a routine basis for many monitoring studies, which 
causes some concern for their representativeness of the underlying 
population. There is an urgent need for standardised guidelines on 
sampling frames for entomological surveillance. 
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3.7.1. IRS and ITN Monitoring 
Malaria control efforts and elimination in Africa are being challenged by 
the development of resistance of parasites to antimalarial drugs and 
vectors to insecticides.  ITNs and IRS are currently the preferred methods 
of vector control especially to suppress transmission in holoendemic and 
hyperendemic scenarios [199]. Enhanced household level protection can 
be achieved if the ITNs and IRS have divergent yet complementary 
properties e.g. highly deterrent IRS compounds coupled with highly toxic 
ITNs. This works on the principle that if indoor resting mosquitoes are not 
repelled by insecticide odor from IRS, they must be then killed by the 
insecticide toxicity on the ITNs. Where both ITNs and IRS are considered, 
the two methods are mostly used concurrently, within the same 
household, even though some national strategies emphasize one method 
more than the other (WHO, 2010). However other than results from a 
small number of previous trials, which had varied primary objectives 
[200-202], there has not been any undisputable empirical evidence that 
ITN-IRS combinations can indeed offer additional communal or personal 
protection, compared to using either method alone. Studies on whether 
the combination of ITNs with IRS or carbamate-treated plastic sheeting 
(CTPS) conferred enhanced protection against malaria and better 
management of pyrethroid-resistance in vectors than did LLINs alone 
showed that there was no significant benefit for reducing malaria 
morbidity, infection, and transmission when combining LLIN+IRS or 
LLIN+CTPS [203]. Similarly, in Eritrea, a study that evaluated the national 
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malaria control programme between 2000 and 2004, showed that there 
was no added advantage of using IRS and ITNs as opposed to using either 
method alone [204]. It was argued that this might have been because the 
predominant vector in the region, An. arabiensis was endophillic and was 
therefore redundantly affected by ITNs and IRS since these interventions 
are both indoors. There are also reports showing that even though 
combination of insecticidal nets with IRS lowered overall vector densities 
inside houses, there was no overall reduction in malaria transmission 
relative to situations where one of the methods was used [161, 162]. 
More recently, Kleinschmidt et al completed a review of studies involving 
both IRS and ITNs in Bioko, Equatorial Guinea and Zambezi province, 
Mozambique [200] and found that in both places, the odds of contracting 
malaria were significantly lower for children living in houses with IRS and 
ITNs, than for children living in houses with IRS alone [200]. 
 
Mathematical modelling has also been adopted as a way of estimating 
potential benefits of combined ITN-IRS interventions [205, 206]. Chitnis et 
al, used a mathematical model to assess the effectiveness of nets and IRS 
when used singly or in combination in a holoendemic area dominated by 
An. gambiae [205]. It was found that using only ITNs are generally better 
protected than those with only IRS, and that even though the ITNs or IRS 
and concluded that a combination of IRS and ITNs would be most 
effective if the second intervention being introduced is initially targeted 
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at those people who are not yet covered by the existing intervention 
[205]. 
 
3.8. Aims and Objectives 
Vector control is critical in reducing malaria transmission to humans and 
related morbidity and mortality. Continuous entomological surveillance is 
of paramount importance in insecticide-based malaria control 
programme to allow for informed decision making on control policy. To 
implement effective vector based intervention strategies, increased 
knowledge on interactions of epidemiological and entomological malaria 
transmission determinants is needed in the assessment of impact 
interventions. In this regard, shifts in the vector resistance status, species 
abundance, sporozoite rates and parasite prevalence that have followed 
in the wake of consistent deployment of these interventions should be 
monitored to generate pragmatic data for informed policy. 
 
The specific objectives of this study were set to; 
 
1. investigate the species diversity and relative abundance of An. 
gambiae s.l. and An. funestus over a one year period in 
Chikhwawa district, pre and post IRS; 
2. monitor insecticide resistance status of An. gambiae and An. 
funestus in Chikhwawa district and 
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3. correlate the entomological indices with malaria parasitaemia 
prevalence in the three sentinel sites. 
 
3.9. Study Hypothesis 
The study was set with a hypothesis that IRS implementation reduces the 
vector population and malaria burden in Chikhwawa. This is based on 
evidence from similar work conducted in Nkhotakota district which 
suggested a substantial impact of IRS using lambda-cyhalothrin on 
parasitemia and anemia prevalence [52]. There are recent reports of 
pyrethroid resistance in An. funestus in Nkhotakota District [157] and 
Likoma Island, and other parts of Malawi where IRS has been 
implemented, [156] phenotypically similar to pyrethroid-resistant An. 
funestus in other parts of southern Africa, [150, 152, 154, 158, 207]. This 
could undermine the efficacy of IRS with pyrethroids and ITNs and 
therefore close monitoring of the IRS program will be needed to assess 
the impact of insecticide resistance on IRS efficacy and to guide the 
choice of insecticide for future spray rounds. Chikhwawa is ideal for this 
monitoring work because; it is one of the districts covered by IRS, has 
intense malaria endemicity [41] and a continuous malaria indicator 
survey has been taking place since May 2010 [208].  
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4. MATERIALS AND METHODS 
4.1. Study design and study period 
4.1.1. Overall study design 
The core study design is a descriptive longitudinal survey, which allowed 
a pre- post IRS comparison as part of ongoing daily surveillance of 
entomological parameters within a group of 18 households from 3 
villages, selected to reflect the likely range of malaria transmission within 
the study area.  
 
The selection of this study design was pragmatic and driven by the 
available funds and set-up. Due to the programmatic scaling-up of 
malaria vector control efforts with IRS throughout the entire district, 
there was no opportunity to implement a more intensive experimental 
study design to assess IRS intervention efficacy, with a randomized 
assignment of the intervention of interest. Withholding IRS to villages or 
households for study purposes was not under our control or ethical at 
this stage of programmatic roll-out by the. Similarly, an alternative 
observational cohort study design, whereby households are selected 
based on the presence or absence of exposure to the intervention of 
interest was not an option for this study. If the IRS campaign would be 
successful, all villages and over 80% of households would receive IRS, and 
those not receiving IRS would unlikely be randomly distributed. Factors 
that would affect individual households not receiving the intervention 
would likely include location (hard-to-reach), household refusal, linked to 
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social economic status /education level or other potential confounders of 
the association between IRS exposure and impact. Contemporary villages 
outside the district were not an option either. While the nearest border 
of the district was relatively close to the selected site, it occurs on the 
Shire escarpment between Blantyre and the Shire valley in Chikhwawa 
districts. As the escarpment includes an 800 metre difference in altitude, 
the transmission setting is entirely different. 
 
Based on this, and due to the limited budget available for my study, I 
opted for continuous surveillance in a selection of households where the 
head of the household indicated they would comply with IRS when it 
would be offered. This would support the 3 objectives, including a pre-
post comparison to assess the change in entomological parameters 
before and after the introduction of IRS. Rolling malaria indicator surveys  
to determine anaemia and parasitaemia in children of less than 5 years 
old in the 50 village catchment area including the 3 sentinel sites was 
carried out in defined periods thoughout the study. A set of households 
was thus enrolled and monitored over an 18-month period to allow for a 
comparison of one high-transmission season pre- and post-roll-out. This 
study design is widely used in programmatic settings, but has a number 
of inherent study design limitations i.e. lack of contemporaneous control 
group. 
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4.1.2. Study objectives and endpoints 
The aim of the study was to assess mosquito abundance and insecticide 
resistance status over time, and assess changes pre- and post IRS. 
 
Primary Objective:  
1. To investigate the species diversity and relative abundance of An. 
gambiae s.l. and An. funestus over a one and half year period in 
Chikhwawa district, pre- and post IRS. 
 
Primary endpoint: 
1. Species specific abundance in the pre-intervention period from 
October 2010 to February 2011 compared to abundance post-IRS 
between March 2011 - July 2011 and October 2011-February 
2012 periods. 
2. Pre- and post IRS comparison of standard transmission indicators 
(sporozoite rates, transmission indices) between October 2010 
and April 2012 periods. 
 
Secondary objectives: 
1. Determine level of insecticide resistance to pyrethroids, and other 
potential alternatives IRS insecticide options. 
Endpoint: 
WHO standard susceptibility assays. 
 
57 
2. Monitor the household wall level of insecticide over 6 months, 
following IRS  
Endpoint:  
Wall Pad colorimetric measurements of the active ingredient of the 
insecticide used during IRS. 
 
3. Assess consistency of entomological findings with the 
contemporaneous findings within a continuous Malaria Indicator 
Surveys within the study area. 
Endpoint:  
Parasitaemia and anaemia results for children within the 
catchment area. 
 
4.1.3. Sample size 
This number of 3 villages and 6 households per village was not based on a 
sample size exercise, but was adopted from sampling frames that had 
been previously used in entomological monitoring surveys in 
Mozambique and Zambia, to ensure consistency [46, 154, 175, 209]. The 
study was done in these three villages bearing in mind the logistical (all-
season road networks) and the prescribed set of criteria as described in 
section 4.3. 
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4.1.4. Study period 
General preparations, installation of exit window traps and the actual 
mosquito collections for the study started in October 2010. A continuous 
malaria indicator survey has been carried out in the study area since April 
2010. The first IRS was planned for October 2010 but was conducted 
from February to March 2011 by the MoH spray teams, due to logistical 
challenges. Figure 3.1 summarises the entire work events for the study. 
 
 
                           Nov     rains 
Figure 4.1 Summary of research activities and timeline 
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4.2. Study Area and Population 
Malawi, situated in south-central Africa, is a landlocked country bordered 
by Tanzania to the north, Zambia to the west and Mozambique to the 
east and south (Figure 4.2). Malawi has an estimated population of 13.1 
million, comprised of approximately 17% children less than five years old 
(Population census, 2008). It has a sub-tropical climate, with three 
distinct seasons. The warm-wet season stretches from November to 
April, during which 95% of the annual precipitation takes place. A cool, 
dry winter season is evident from May to August with mean 
temperatures varying between 17°C and 27°C, with temperatures falling 
between 4°C and 10°C. In addition, frost may occur in isolated areas in 
June and July. A hot, dry season lasts from September to October with 
average temperatures varying between 25°C and 37°C. Annual average 
rainfall varies from 725mm to 2,500mm. Humidity ranges from 50% to 
87% for the drier months of September/October and wetter months of 
January and February respectively 
(http://www.metmalawi.com/climate/climate.php). 
 
Chikhwawa is located in the Lower Shire Valley within the Great African 
Rift Valley (Fig 4.2 and Fig 4.3) and malaria control has been scaled up 
considerable over the past 10 years [25, 210-213]. In 2008 Chikhwawa 
had an estimated total population of 438,895. Annual Population growth 
rate is 1.1% and an average family size is 4.5 [27]. 
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It is bordered with four districts, namely Mwanza to the North, Blantyre 
to the North East, Thyolo to the East, Nsanje to the South and Nsanje in 
the South and it also shares an international border with Mozambique to 
the West. Chikhwawa has an altitude of about 70m above the sea level 
and entirely cut through by Shire River, the largest river in Malawi and 
the only outlet of Lake Malawi, making it viable flood plain for irrigation 
agriculture. Chikhwawa experiences mean annual temperature of about 
26°C with minimum temperatures in June and July and maximum 
temperatures in October and November. The area receives mean tropical 
rainfall of 775 mm per annum (district wide data from Nchalo 
Meteorological Centre). 
 
In terms of agriculture, Chikhwawa has a long history of irrigation, arable 
and livestock farming (personal communication by the District 
Agricultural Officer). The total land area is 471, 957 hectares of which 20, 
118 hectares is dry arable land and 29,962 hectares is wet arable land 
(Waterforpeople.org, 2011). It is one of the largest cotton and sugar cane 
growing districts in Malawi. Cotton is the major cash crop grown in the 
area and the other crops include maize, millets, sorghum, rice beans and 
vegetables. Pyrethroids are a major class of insecticides commonly used 
for growing cotton in the area [214]. From 2005 there has been large 
scale free distribution and selling of insecticides to farmers at subsidised 
rates through the Shire Valley Agricultural Development Division (SVADD) 
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in a programme called the Farmers Input Subsidy (Personal 
Communication). 
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Figure 4.2: Map showing position of Malawi in Africa and the location 
of Chikhwawa District in Malawi shown in Yellow in the main map. 
 Malawi 
Chikhwawa 
District 
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4.3. Study Procedures 
4.3.1. Village and Household Selection 
Following consultation with the District Environmental Health Officer 
(DEHO), three sentinel sites were selected from the 50 villages in the 
catchment area of the Artemisinin Combination Therapy in action (ACTia) 
project [208] in Chikhwawa (16° 1’ S, 34° 47’ E) namely; Mwingama, 
Namila and Tsekera (Figure 4.2 and 4.3). The 3 villages were selected 
based on their distance from the Shire River, which provides a source of 
water for larval breeding and secondly with the aim to capture and 
represent the baseline variation in mosquito abundance in the area 
before IRS. One village was selected near the Shire River (<~ 1km), 1 
village within 1-9km, and 1 village further from the river (>= 10 km) (Fig 
4.3). Eligible villages also had to be accessible easily by road throughout 
the year to accommodate the monthly mosquito collections and any 
unannounced spot checks for quality control purposes. 
 
4.3.1.1. Household eligibility criteria:  
For the selection of households, I prioritized characteristics that would 
support continuous, accurate collection of mosquito abundance over 
time, rather than representativeness of households of the overall 
underlying population. Representative would be difficult to achieve with 
the small numbers of houses, and the design focused on a pre-post 
comparison that focuses on capturing change within a single group rather 
than difference between two groups. 
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Three standard physical attributes were used to select households for 
this entomological activity. Firstly, the household needed to be 
permanent and be available for the whole study period (>1.5yrs). 
Secondly, the household needed to have a separate kitchen from the 
bedroom or main house so that kitchen smoke should not darken the 
white window trap nor confound with mosquito abundance and 
migration within the house. This aspect has a limitation of increasing the 
estimates of mosquito abundance. Finally, a consideration was made on 
choice of houses with minimal open eaves to allow for easy mounting of 
the exit window trap.  This however would operationally reduce the 
mosquito abundance. The three villages selected for the study had 
general similarity in terms of the type of houses found; social economic 
status, agricultural type, literacy levels and general geographical 
characteristics i.e. soil type and terrain. 
 
With assistance from the village chief or his representative the selected 
villages were divided into 3 strata of approximately equal size to ensure 
spatial representation within each of the selected villages. The 
approximate centre point was determined for each of the 3 strata, and 
using a list of household eligibility criteria, 2 eligible households were 
selected nearest to each centre point.  If the household owner could not 
count and read or was less able to independently perform the collection 
task or declined, the nearest next eligible household was selected, from 
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the same strata. Prior knowledge of whether the household structure 
would be permanent or not over the duration of the collection, was also 
taken into consideration when selecting the households. A total of 6 
households were thus selected and window exit traps installed in each 
village. 
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Figure 4.3 Map of Chikhwawa District showing the three sentinel sites 
and the 50 village catchment area for ACTia drug trial. 
 
Chikhwawa District 
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Namila 
Tsekera 
Mwingama 
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4.3.2. Village description 
44.3.2.1    Mwingama Village 
Mwingama village (16° 1' S, 34° 47' E) is located within the main town of 
the district and closest to the district referral hospital. It is about 2 
kilometres from the Shire River and has combined modern and 
traditional households. The village has 2 main boreholes that provide 
water to the village and pools of water are found at these sites that 
potentially breed mosquitoes. In terms of agriculture, Mwingama has rice 
paddies; villagers grow cereals and vegetables and also rear goats, pigs, 
poultry and cattle.  There are 112 households with a population of 
approximately 600 people. IRS was conducted on 12th February 2010 and 
all 6 households where window exit trap collections were ongoing were 
sprayed (Fig 4.4). 
 
44.3.2.2   Namila Village 
Namila (16° 0' S, 34° 49' E) is 15 kilometres northeast of Chikhwawa town 
centre. It has 277 households with a population of approximately 1200 
people. The village is 10 kilometres away from the Shire River. It is close 
to a seasonal river called Likhubula, which dries up in dry season. Namila 
has traditional earth made houses thatched with grass and open eaves. 
The majority of homeowners are subsistence farmers rearing pigs, goats, 
poultry, and cattle. IRS was carried out on 28th February 2012 covering 
every household with an exit window trap (Fig. 4.4). 
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44.3.2.3   Tsekera village 
Tsekera village (15° 59' S, 34° 46' E) is located to the southwest of the 
Chikhwawa town centre. The village is about 100 metres from the Shire 
River bed. It has 3 boreholes that provide off-river source of water and 
pools of water that can act as breeding sites for mosquitoes.  The people 
are subsistence farmers, growing rice and cereals (maize, sorghum and 
millet) and many households rear pigs, goats, chickens and cattle.  The 
village comprises of 60 households with a population of approximately 
300 persons. The houses are typical traditional earth made with grass 
thatched roofs and open eaves. IRS was carried out on 17th February 
2012. Every household with exit window trap was sprayed in Tsekera (Fig 
4.4). 
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Fig 4.4. Arial view of Mwingama, Namila and Tsekera sentinel sites showing collection points within the village 
potential breeding sites. 
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4.3.3. Assessment of Mosquito Species and Abundance  
Informed consent was obtained from homeowners who had shown 
interest to take part in the study (Appendix 1) and comprehensive training 
was provided to every household owner to show them how to undertake 
the daily mosquito collections. Safety information on handling of 
isopropanol, and other collection material as well as a practical illustration 
of the entire mosquito collection and recording process was conducted 
with a practice exercise to confirm understanding at every household. 
Refresher trainings and general update meetings were facilitated at each 
monthly visit to enhance the quality of the collection and identify and 
resolve potential problems encountered by the household owners in the 
course of the collection. A monthly stipend of $10 was given to each 
household owner as reimbursement for their time spent on collection. 
Window exit traps were installed in mid October 2010 on six houses from 
each sentinel site (18 traps in total) ahead of the rains and IRS intervention.  
Each household was provided with a tray of pre-labelled specimen jars 
containing isopropanol, a checklist form and an aspirator. Collection of 
mosquitoes was done daily at the following times; 6:00 a.m and 12:00 
noon to ensure minimal escapees from the traps. Routine and surprise 
spot check visits were conducted for quality control purposes to check 
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whether the household owner was collecting the mosquito’s and 
documenting the collections as per study operating procedures. 
Mosquitoes were then stored in the isopropanol specimen jars. Trays were 
retrieved monthly and household owners were asked to complete a 
checklist indicating the nights when the mosquitoes were collected [155]. 
Torn and worn out traps were reported and immediately replaced. All 
Culicines caught in the traps were recorded to ensure that in the absence 
of Anopheline catches, the traps were being operated successfully [46]. 
Mosquito specimens were sent to Chikhwawa District hospital laboratory 
for morphological species identification before being shipped to the 
Liverpool School of Tropical Medicine (LSTM) for species identification and 
sporozoite detection. 
 
4.3.3.1. Morphological species identification  
The collected mosquitoes were segregated into anophelines and culicine 
and enumerated at Chikhwawa District hospital laboratory. All anophelines 
were identified as An. gambiae complex or An. funestus group using 
morphological keys [55, 63] and individually stored on silica gel in micro-
centrifuge tubes. Samples were then transported to LSTM for subsequent 
molecular analysis. 
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4.3.3.2. Molecular Identification to species level 
Total genomic DNA (gDNA) was extracted from each mosquito head and 
thorax individually, using Qiagen DNeasy® 96 Blood and Tissue kit’s 
according to manufacturer instruction, except with two amendments; At 
step 1 the mosquito tissue was disrupted using a QIAGEN Tissuelyser for 15 
minutes at 30Hz after the addition of a stainless steel ball bearing, Buffer 
ATL and proteinase K to each collection tube. At step 16 and 17 the gDNA 
was eluted from the column using 50 µl only of elution buffer. Polymerase 
Chain Reaction (PCR) was then used to determine the species of each 
individual mosquito. 
 
4.3.3.3. Anopheles gambiae Complex 
Species identification was carried out using an adapted version of Scott et 
al [99]. A 25µl reaction was set up as follows; 1µl gDNA, 2.5µl 10X PCR 
Buffer, 0.25µl MgCl (50mM), 0.175µl Taq DNA polymerase, 0.5µl dNTPs 
(10mM), 18.24µl dH20, 10mM primers of the following volumes; 0.624µl 
GA, 1.248µl UN, 0.463µl AR. PCR cycling conditions were set at 95°C for 5 
min followed by 35 cycles of 95°C for 30 s, 50°C for 30 s,  72°C for 30 s and 
a final extension of 72°C for 10 min and held at 10°C until taken off the PCR 
machine and stored at 4°C. The amplified fragments were analysed using 
1.5% agarose gel containing ethidium bromide and visualised under UV 
light. 
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Table 4.1 Primer sequences of species-diagnostic An. gambiae complex. 
GA = An. gambiae s.s, ME = An. melas/merus, AR = An. arabiensis, QD = An. 
quadrianuulatus and UN = Universal  
 
4.3.3.3.1. Anopheles funestus Group 
Anopheles funestus samples were species identified by PCR according to 
Koekemoer et al [215] and An. funestus-like according to Spilling et al 
[113].  Primers AFUN or MalaFB were used to amplify products diagnostic 
for An. funestus s.s (505 bp), and An. funestus-like (390 bp) respectively 
along with the internal transcribed spacer region 2 (ITS2A) primer. A 25 µl 
PCR reaction was then set up as follows; 1µl gDNA, 2.5µl 10X PCR Buffer, 
1µl MgCl (50mM), 0.75µl Taq DNA polymerase, 2µl dNTPs (10mM), 0.5µl 
(10mM) of primers AFUN/MalaFB and ITS2A, and 16.75µl dH20.  Cycling 
conditions were set at 94°C for 5 min followed by 35 cycles of 94°C for 30 
s, 50°C for 30 s, 72°C for 30 s and a final extension of 72°C for 10 min and 
a hold at 10°C. Cycling conditions for An funestus-like identification were 
set as 94°C for 2 min’s followed by 35 cycles of 94°C for 30 s, 45°C for 30 s,  
72°C for 40 s and a final extension of 72°C for 5 min and a hold at 10°C. 
Primer 
name 
Species name Primer sequence 
(5’ to 3’) 
Band 
size 
GA An. gambiae s.s CTGGTTTGGTCGGCACGTTT 390 
UN - GGTTGCCCCTTCCTCGATGT - 
ME An. melas/merus TGACCAACCCACTCCCTTGA 466 
AR An. arabiensis AAGTGTCCTTCTCCATCCTA 315 
QD An. 
quadriannulatus 
CAGACCAAGATGGTTAGTAT 153 
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PCR reactions were then stored at 4°C until the amplified fragments were 
analysed on 1.5% agarose gels containing ethidium bromide and 
visualised under UV light. 
 
Primer 
name 
Species 
name 
Primer sequence (5’ to 
3’) 
Band 
size 
Tm 
(0C) 
 
AFUN An. funestus 
s.s 
CGATCGATGGGTTAATC
ATG 
505 52.4 
ITS2A - TGTGAACTGCAGGACAC
AT 
- - 
MalaFB An. funestus-
like 
GTTTTCAATTGAATTCAC
CATT 
390 - 
Table 4.2 Primer sequences of species-diagnostic An. funestus s.s, An. 
funestus-like and ITS2A (Universal) [215, 216]. 
 
4.3.3.4. Sporozoite Detection  
Sporozoite detection was carried out on all gDNA samples of An. gambiae, 
An. arabiensis, An. funestus s.s, and An. funestus-like which were 
successfully identified using real time PCR (RT-PCR) as described by Bass 
et al [217]. Each reaction consisted of; 1µl gDNA, 10µl of 2x SensiMix 
probe (Bioline), 4.2µl dH2O, 400nM final concentration of each probe by 
adding 0.8µl of 10µM probe PlasF+ (6FAM-TCTGAATACGAATGTC) and 
0.8µl of 10µM OVM+ (VIC-CTGAATACAAATGCC), and 800nM final 
concentration of each primer by adding 1.6µl PlasF 
(GCTTAGTTACGATTAATAGGAGTAGCTTG) and 1.6µl PlasR 
(GAAAATCTAAGAATTTCACCTCTGACA). Samples were run on an Mx3005P 
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qPCR machine and the assay conditions were set as follows: 95°C for 10 
min followed by 50 cycles of 95°C for 10 s and 60°C for 45 s. The increase 
in VIC and FAM fluorescence was measured at the end of each cycle on 
the yellow (530nm excitation and 555nm emission) and green channel 
(470 nm excitation and 510 emission) respectively. Positive samples were 
verified by analysing the amplification curves of samples relative to 
positive controls (MRA-273G, MRA-341G and a P. falciparum positive 
control gDNA sample) and with a cut-off point for the Ct value of 40 after, 
the threshold was set above background detection. Samples, which were 
positive between Ct values 40-45 were subjected to further testing and 
analysis for confirmation. 
 
4.3.3.5. Data analysis  
The numbers of mosquitoes per trap per night were calculated for each 
species based on day of capture of the specimen. Prevalence for specific 
species sporozoites and the number of infected mosquitoes per trap per 
night (transmission index) was determined. Sporozoite rates, number of 
mosquitoes per trap per 100 nights, transmission index and relative 
transmission index, percentage proportion of species and their estimated 
numbers were calculated using the following formulae: 
 Sporozoite rate = the number of Anopheles infectious with 
sporozoites ÷ the total number tested for sporozoites. 
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 Number of mosquitoes per trap per 100 nights = (Total number of 
An. mosquitoes collected ÷ Total number of collection nights ÷ 
Total number of exit traps) x 100. 
 Transmission index = Number of mosquitoes per trap per night x 
Sporozoite rate. 
 Relative transmission index = Transmission Index ÷ Transmission 
index at base line 
 An. gambiae s.s proportion (%) = (Total number of An. gambiae s.s 
÷ Total number of An. gambiae s.l) x 100. 
 An. funestus s.s proportion (%) = (Total number of An. funestus s.s 
÷ Total number of An. funestus s.l) x 100  
 
The changes in vector abundance and transmission parameters were 
assessed using Wilcoxon sign rank test. 
4.3.4. Assessment of Mosquito Insecticide Resistance 
Live collections were carried in randomly selected households within the 
three sentinel sites targeting indoor-resting adult female Anopheline 
mosquitoes pre and post IRS. Houses that had window exit traps were 
deliberately skipped for live collections to avoid confounding the 
abundance results. The first collections were carried out in December 
2010 before the IRS intervention and then routinely after the spray. 
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Indoor resting blood fed adult female An. gambiae s.l and An. funestus 
were collected between 05.30-10.00 h in houses using a mouth aspirator.  
Live mosquitoes were then transported to Malaria Alert Centre insectary 
in Blantyre and kept in individual oviposition tubes with damp filter paper, 
provided with 10% sucrose, and allowed to lay eggs. Eggs were allowed to 
hatch in a small cup and latter transferred to bowls of water for rearing. 
The larvae were fed with TetraminTM baby fish food daily. Water in each 
larval bowl was changed every two days to reduce mortality due to poor 
water quality [158]. Each family was reared separately through to 1-3 day 
old F1 adults at 26°C +/- 2°C and 70-80% relative humidity. Families were 
mixed prior to testing to avoid bias from isofemale lines where offspring 
may all be genetically similar [218]. 
 
4.3.4.1  WHO Susceptibility Tests 
Standard WHO susceptibility assay were carried out, exposing between 5 
and 25, F1 3-5day old adult mosquitoes to insecticide treated, or control 
papers impregnated with the carrier oil alone, for 1 hour and then 
transferred to holding tubes with access to 10% sugar solution for 24 
hours before the percentage mortality was determined. The insecticides 
tested were, bendiocarb (0.1%), deltamethrin (0.05%), etofenprox (0.5%), 
lambda-cyhalothrin (0.01%), malathion (5%), and permethrin (0.75%). 
Treated test papers with the WHO diagnostic dosages were supplied by 
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the WHO Collaborating Centre in Penang, Malaysia [156]. All dead 
mosquitoes post exposure to the insecticides were preserved in silica gel 
for molecular species identification, whilst the survivors were kept 
separately in RNAlater. 
 
WHO insecticide resistance assay results were categorised according to 
percentage mortality as; susceptible, requiring confirmation of resistance, 
or resistant. This standard is recommended by WHO [219] and has been 
used by the African Network for Vector Resistance (ANVR) and has been 
adopted for the thesis (Table 4.3 )  
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 At least 80 mosquitoes 
tested per bioassay 
20 to 79 mosquitoes 
tested per bioassay 
Susceptible Mortality 98 – 100% Mortality 98 – 100% 
Resistance 
suspected, to be  
confirmed 
Mortality 95 – 97% Mortality 80 – 97% 
Resistance Mortality < 95% Mortality <80% 
 
Table 4.3: Criteria for interpretation and classification of results, based on 
WHO recommendations [219]. 
 
4.3.4.1. Data Analysis for insecticide resistance 
Chi square test was used to compare insecticide susceptibility assay 
results over time from the same locality [154] and was calculated as 
follows:  
 Chi square: X2 = ∑(O-E)2/E = Sum of Number of [(observed number 
– expected number)2] ÷ expected number. 
Where; 
X2 = Sum of total number of (O-E)2/E computations, 
O = Observed number, 
E = Expected number. 
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Where the observed numbers were small (<5), Fischer’s exact test was 
used to compare susceptibility assay results over time from the same 
locality. 
 
4.3.5. Assessment of Insecticide Quantification within Sprayed 
Households  
Post-spray insecticide concentrations on household walls were 
determined using a newly developed Insecticide Quantification Kit that 
used colorimetric analysis of insecticide content on felt wall pads 
according to Paine et al (Unpublished). 
 
4.3.5.1.  Field Application of Insecticide Quantification Kits (IQK) 
Before the actual spraying, three felt pads were attached in duplicate to 
the walls of the same households that had exit window traps at each of 
three positions, top, middle and bottom.  Details about the dates at which 
the wall pads were stuck or pulled off, household identification number 
and position were documented. Being small, the pads were less obvious 
to sprayers, who were not informed of the test and unaware of the 
location of the houses chosen or the purpose of the small pads. Each pad 
was 10mm diameter, 1mm thick and obtained from Game Stores, Chichiri, 
Malawi. One sample was taken in each house at random height at least 
three weeks after the spray to measure post-spray concentration and 
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then stored in a polythene bag at 4oC in Blantyre, Malawi, before IQK 
analysis were done at LSTM, UK. Duplicate samples were taken for 
calorimetric analysis of insecticide content according to Paine et al 
(Unpublished). 
 
4.3.5.2. Insecticide Quantification 
For colorimetric measurement of lambda-cyhalothrin individual pads 
were dropped into a glass tube labeled with sample number.  The IQK 
detection reagents were added to each tube as follows;  
 800 µL Reagent A (0.075% solution of potassium  hydroxide in 
90% ethanol) 
 800 µL Reagent B (400mg TTC and 40mg PNB, dissolved in 
100ml  with 90% ethanol) 
 Incubate at RT for 15 min. with frequent mixing  (vortexing if 
available)  
 Add 400 µL reagent C (0.5ml of acetic acid in 100ml water; 
0.5% final dilution).  
A colour chart was prepared to compare observed levels by spiking  pad 
size (1cm2) 3mm filter papers with the active ingredient, lambda-
cyhalothrin, as follows; a stock solution of  lambda-cyhalothrin was 
prepared in 100% methanol. The filter papers were spiked with the 
following stock volumes; 1, 3, 5, 10, 20, 30 and 40 µl.  A zero control was 
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prepared with 100 µl methanol. The filters were taken through the IQK 
procedure to provide the red colour range equivalent to wall spray rates 
of 0, 1, 2, 3, 5, 10, 20, and 40 mg/m2 respectively. To produce the chart, 
the dilution range was transferred to clear plastic cuvettes (1 cm light 
path), and a picture taken against a white background.  After importing 
into Powerpoint, representative red areas for each dilution were cropped 
and cut and pasted to produce a colour strip with depths of red colour 
representative of m2 spray rates.  Observed levels were compared visually 
against this colour strip for calorimetric analysis of insecticide content, to 
estimate the quantity of the residual insecticide of individual samples. 
 
4.3.6. Assessment of Human Burden Impact Indicators 
4.3.6.1. The Rolling Malaria Indicator Surveys (rMIS) 
The rolling malaria indicator surveys (rMIS) were initiated in May 2010 
and coordinated by the Malawi-Liverpool-Wellcome Trust (MLW) team 
based in Chikhwawa District Hospital. The MLW team was responsible for 
general management of the survey activities, including oversight of day-
to-day operations, design of the survey and obtain ethical approval (both 
from the Liverpool School of Tropical Medicine Research Ethics 
Committee and College of Medicine Research Ethics Committee 
(COMREC), recruiting and training field staff, and providing necessary 
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medications for field activities. The MLW team also led the data 
processing activities, report writing and data dissemination. 
 
The rMIS covered 50 villages in Chikhwawa district (~1/10 of the entire 
district) including the sentinel sites of this study (Fig 4.3). The design for 
the survey was a representative probability sample to produce estimates 
for the study area as a whole and each season separately. To assess 
differences between the rainy season from November to April, and dry 
season from May to October, every village was sampled once in each six-
month period (once during the rainy season and once during the dry 
season). On average, a six-month gap between first and second sample 
for each village was ensured to avoid treatment interference on first 
survey with burden assessments on the second survey. 
 
Households were randomly selected using a two-step sampling strategy. 
During each season, all 50 villages were randomly assigned to one of the 
six months (8 or 9 villages per month). Within each village, households 
were randomly selected from a list of households, with a probability 
proportional to village population size. This sampling frame was based on 
a research-driven census exercise of the entire study area conducted by 
the study team in November 2008. 
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4.3.6.2. Malaria parasites and anaemia testing 
All nurses recruited for the rolling MIS received standardized training to 
conduct finger pricks for anaemia and malaria parasitaemia among 
children six months to 59 months. Blood samples were collected to 
prepare a thick and thin blood film, determine the child’s haemoglobin 
concentration using a Hemocue photometer (HemoCue Haemoglobin 301 
analyser, Hemocue Ltd, UK), and guiding treatment of parasitaemic 
children in the field by conducting a rapid malaria-diagnostic test (RDT) 
strip (First Response Malaria Ag pLDH/HRP2 Combo, Premier Medical 
Corporation Ltd. India) . Results from the anaemia testing and RDTs were 
available immediately to the parents or caregivers for the child. Children 
with a positive RDT and without clinical evidence for severe malaria 
classification received treatment on the spot for malaria using Coartem® 
from study research nurses, according to Malawi national treatment 
guidelines. Children clinically assessed by the survey nurse to need further 
medical assessment and care were referred and assisted with transport to 
the Chikhwawa District Hospital. Those already treated with Coartem® 
within the past two weeks were also referred to Chikhwawa District 
Hospital for additional evaluation. 
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4.3.6.3. Slide examination 
Children found to be parasitaemic (by RDT) or anaemic were treated as 
per national malaria treatment guidelines. Questionnaires were pre-
programmed into the PDAs (Somo 650®, Socket Mobile, Newark, 
California) programmed in Visual CE® 11.1 language (Syware 
Incorporation, Cambridge, Massachusetts) to eliminate the need for 
paper-based questionnaires. Both, Hemocue (HemoCue B-Hemoglobin®, 
HemoCue AB, Ängelhom, Sweden) and RDT (First Response® Malaria Ag. 
pLDH/HRP2 Combo Card Test, Premier Medical Corporation Ltd., India) 
testing were performed according to manufacturer recommendations.  
 
4.4. Ethical approval  
The Research Ethics Committees of the College of Medicine in Blantyre 
(COMREC) (refs P.08/10/970 and P.10/08/707) and the Liverpool School 
of Tropical Medicine (refs 09.07 and 10.78) provided ethical approval for 
the ACTia main study. Permission to work in specific villages was granted 
by each village chief following an initial briefing meeting at which the 
nature, objectives of the study were explained to all members of the 
community in local language, Chichewa. Written informed consent was 
obtained at the beginning of the study. On the day of live mosquito 
collection, the purpose of the work was again explained to each 
householder, and permission to enter the house was sought. 
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5. RESULTS 
5.1. Vector Abundance and Transmission indicators 
5.1.1. Vector Species Identification 
A total of 3395 Anophelines were collected from 18 window exit traps 
over a 577 trapping night period (October, 2010 to April 2012). Of these, 
607 (18%) were collected from Mwingama, 270 (8%) from Namila, and 
2518 (74%) were collected from Tsekera. From the total Anophelines 
collected, 1715 were morphologically identified as An. gambiae s.l (50.5%) 
and 1680 were identified as An. funestus s.l (49.5%). Of these, 1396 An. 
gambiae s.l and 1063 An. funestus s.l were further identified to species 
level using PCR (Tables 5.1, 5.2 and 5.3). Anopheles gambiae s.s and An. 
arabiensis were the two members of the An. gambiae complex identified 
and An. funestus s.s was the only member of An. funestus group 
identified, all three species were found at all three sites (Tables 5.1, 5.2 
and 5.3).  
 
5.1.2. Vector Species Abundance 
In the period leading up to IRS, October 2010 to February 2011, the total 
number of An. gambiae s.l and An. funestus s.l caught from Mwingama 
was 228 and 187 respectively. From this, the calculated number of An. 
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gambiae s.s, An. arabiensis and An. funestus s.s caught per window trap 
per 100 nights was 0.35, 24.3 and 17.6 respectively (Table 5.3). Following 
IRS, March 2011 to July 2011, there was a decline in mosquitoes being 
caught, with only 6 An. gambiae using Wilcoxon test (z = 0.97, p = 0.33) 
and 19 An. funestus (z = 3.2, p = 0.75). The calculated number of An. 
gambiae s.s, An. arabiensis and An. funestus s.s caught per window trap 
per 100 nights for Mwingama was 0.13, 0.53 and 1.51 respectively. 
Normally there would be a natural reduction in the mosquito population 
at this time, as the rains would decline, however, the peak rainfall was 
later than expected for the malaria season of 2010/11 (Fig 5.1). Decline  in 
abundance are best observed when comparing two comparable seasons, 
i.e., October 2011 to Feb 2012, where a decline is observed, 14 An. 
gambiae (z = 0.74, p = 0.46) and 6 An. funestus (z = 0.21, p = 0.83) despite 
a higher rainfall in the second season and an expected increase higher 
abundance. Culicines were collected in window exit traps suggesting that 
these were still well operated throughout the study. Fig 5.1 summarises 
the comparisons of the mosquito numbers caught per village before and 
after IRS. 
 
A decline in An. gambiae and An. funestus also occurred in Namila 
following IRS. The number of An. gambiae s.l and An. funestus s.l, from 
October 2010 to February 2011, was 70 and 76 respectively (Fig 5.2). The 
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calculated number of An. gambiae s.s, An. arabiensis and An. funestus s.s 
caught per window trap per 100 nights was 0, 6.33 and 5.40 respectively. 
Following IRS, March 2011 to July 2011, there was a significant decline in 
mosquitoes being caught with only 5 An. gambiae (z = 2.4, p = 0.02) and 
26 An. funestus. The number of An. gambiae s.s, An. arabiensis and An. 
funestus s.s caught per window trap per 100 nights for Namila over this 
period dropped to 0, 0.44 and 0.85 respectively. The decline in abundance 
for this site was observed when comparing pre IRS with mosquito 
abundance of the corresponding season, of October 2011 to Feb 2012, 
where significant decline in An. gambiae (n = 16, p = 0.05) and An. 
funestus (n = 3, p = 0.17) (Fig 5.2). 
 
Mosquito decline was also observed at Tsekera where the number of An. 
gambiae s.l (1097), and An. funestus s.l (766) caught before IRS dropped 
to 187 An. gambiae (p = 0.35) and 233 An. funestus (p = 0.92) from March 
to July 2011. The calculated number of An. gambiae s.s, An. arabiensis 
and An. funestus s.s caught per window trap per 100 nights was 3.74, 117 
and 63.9 respectively (Table 5.4). Despite a higher rainfall in the second 
season and an expected increase higher abundance, only 1 An. gambiae 
s.l (p = 0.07) and 1 An. funestus s.l (p = 0.17) was collected at Tsekera from 
October 2011 to February 2012.  
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Fig 5.1 Anopheles mosquito species abundance in the three sentinel sites 
and district level monthly rainfall distribution. 
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Fig 5.2 Anopheline and non Anopheline mosquito abundance in the 
sentinel sites pre and post IRS. 
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Table 5.1 Vector Abundance, Infectivity and Transmission Index for Mwingama Pre 
and Post IRS Intervention 
 Pre IRS Post IRS 
 Oct 2010 – 
Feb 2011 
Mar - July 
2011 
Oct 2011 –
Feb 012 
An. gambiae s.l    
No. Caught 228 6 14 
No. Analysed for species id 219 5 14 
No. An. gambiae s.s 3 1 0 
No. An. arabiensis 215 4 14 
No. Others 1 0 0 
No. An. gambiae s.s proportion 
(%) 
1.32 20 0 
An. gambiae s.s    
No. Estimated 3.12 1.2 0 
No. An. gambiae s.s per trap per 
100 nights 
0.34 0.13 0 
Sporozoite Rate 0 (n=3) 0 (n=1) 0 (n=0) 
Transmission Index 0 0 0 
An. arabiensis    
No. Estimated 224 4.8 14 
No. An. gambiae s.s per trap per 
100 nights 
25 0.53 1.57 
Sporozoite Rate 0.03 
(n=215) 
0 (n=4) 0.07 
(n=14) 
Transmission Index 0.92 0 0.11 
No. An. arabiensis proportion 
(%) 
98.2 0.8 100 
An. funestus s.l    
No. Caught 187 19 6 
No. Analysed for species id 117 16 6 
No. An. funestus s.s 100 14 5 
No. An. funestus proportion (%) 85.5 87.5 83.3 
An. funestus s.s    
No. Estimated 160 16.6 5 
No. per trap per 100 nights 18 1.51 0.56 
Sporozoite rate 0.02 
(n=117) 
0 (n=17) 0.17 (n=6) 
Transmission Index 0.3 0 0.1 
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Table 5.2 Vector Abundance, Infectivity and Transmission Index for Namila Pre and 
Post IRS Intervention 
 Pre IRS Post IRS 
 Oct 2010 – 
Feb 2011 
Mar - July 
2011 
Oct 2011 –
Feb 012 
An. gambiae s.l    
No. Caught 70 5 16 
No. Analysed for species id 70 5 16 
No. An. gambiae s.s 0 0 0 
No. An. arabiensis 57 4 16 
No. Others 13 1 0 
No. An. gambiae s.s proportion 
(%) 
0 0 0 
An. gambiae s.s    
No. Estimated 0 0 0 
No. An. gambiae s.s per trap per 
100 nights 
0 0 0 
Sporozoite Rate 0 (n=0) 0 (n=0) 0 (n=0) 
Transmission Index* 0 0 0 
An. Arabiensis    
No. Estimated 57 4 16 
No. An. gambiae s.s per trap per 
100 nights 
6.3 0.44 1.79 
Sporozoite Rate 0 (n=57) 0 (n=4) 0.07 
(n=16) 
Transmission Index* 0 0 0.11 
No. An. arabiensis proportion 
(%) 
8.4 0.8 100 
An. funestus s.l    
No. Caught 76 26 3 
No. Analysed for species id 72 25 3 
No. An. funestus s.s 46 9 3 
No. An. funestus proportion (%) 63.9 36 100 
An. funestus s.s    
No. Estimated 48.6 9.4 3 
No. per trap per 100 nights 5.4 0.85 0.34 
Sporozoite rate 0.03 
(n=72) 
0 (n=25) 0.17 (n=3) 
Transmission Index* 0.15 0 0.11 
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Table 5.3 Vector Abundance, Infectivity and Transmission Index for Tsekera Pre and 
Post IRS Intervention 
 Pre IRS Post IRS 
 Oct 2010 – 
Feb 2011 
Mar - July 
2011 
Oct 2011 –
Feb 012 
An. gambiae s.l    
No. Caught 1097 187 1 
No. Analysed for species id 815 161 1 
No. An. gambiae s.s 25 0 1 
No. An. arabiensis 785 161 1 
No. Others 5 0 0 
No. An. gambiae s.s proportion 
(%) 
3.07 0 0 
An. gambiae s.s    
No. Estimated 3.4 0 0 
No. An. gambiae s.s per trap per 
100 nights 
3.74 0 0 
Sporozoite Rate 0.08 
(n=25) 
0 (n=0) 0 (n=0) 
Transmission Index* 0.03 0 3 
An. Arabiensis    
No. Estimated 1057 187 1 
No. An. gambiae s.s per trap per 
100 nights 
117.4 20.6 0.01 
Sporozoite Rate 0.02 
(n=785) 
0.02 
(n=161) 
0 (n=1) 
Transmission Index* 1.94 0.51 0 
No. An. arabiensis proportion 
(%) 
96 1 100 
An. fune3stus s.l    
No. Caught 766 236 1 
No. Analysed for species id 245 207 1 
No. An. funestus s.s 184 182 1 
No. An. funestus proportion (%) 75.1 87.9 100 
An. funestus s.s    
No. Estimated 575 207.5 1 
No. per trap per 100 nights 63.9 18.9 0.1 
Sporozoite rate 0.01 
(n=245) 
0.09 
(n=207) 
0 (n=1) 
Transmission Index* 4.17 1.64 0.11 
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Table 5.4 Mosquito collections per trap per 100 days from the sentinel sites 
5.1.3. Sporozoite Rates  
Sporozoite rates were determined in all the identified malaria vector 
species. In the period October 2010 to February 2011 The An. funestus s.s 
sporozoite rate for Mwingama, Namila, and Tsekera was 2%, 4% and 8% 
respectively. During the post IRS period this was 0 at Mwingama and 
Namila (P = 0.137) and 8% at Tsekera from March to July 2011 (Tables 5.1, 
5.2 and 5.3). 
 
As no An. gambiae were found between Oct 2010 and Feb 2011 during 
the pre-IRS assessment, no sporozoite rates could be determined for An. 
gambiae at Mwingama and Namila pre IRS, whilst that of Tsekera was 
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0.08%. There was no An. gambiae collected in the period October 2011 to 
February 2012, and therefore no sporozoite was detected. 
 
5.1.4. Transmission Index 
The transmission index is defined as the average number of female 
Anopheles found with sporozoite in the salivary glands per room per day. 
Transmission index for An. gambiae (all sites combined) was 0.003 before 
IRS and 0 in the following time period from October 2011 to February 
2012. An. funestus transmission index declined from 3.2 before IRS to 0.1 
over the period October 2011 and February 2012. 
 
Transmission index was recorded when the sites were taken individually. 
Anopheles funestus s.s transmission index, pre IRS, was 0.3 for 
Mwingama, 0.1 for Namila and 4.17 for Tsekera. Following IRS, from 
February to July 2011, the transmission index fell to 0 at both Mwingama 
and Namila and 1.64 at Tsekera (Tables 5.1, 5.2 and 5.3). 
 
5.2. Insecticide Resistance 
A total of 2213 Anopheles were obtained from the indoor live catches in 
all the three sentinel sites between from October 2010 to February 2012, 
of which 199 (9%) were An. gambiae s.l and 2014 (91%) were An. funestus 
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s.l. Of these 67 An. gambiae and 302 An. funestus laid eggs that were 
reared to 1-3 day old F1 generation and assayed for insecticide 
susceptibility using WHO protocol. A total of 695 An. gambiae s.l and 2516 
An. funestus s.l were assayed. 
 
Insecticide resistance status was based on percentage mortality. Based on 
the WHO definition, clear insecticide resistance was only found to 
deltamethrin in An. funestus (77% mortality) from Namila in 2011 (Table 
5.4). Tests on all other insecticides showed suspected resistance in both 
species of mosquitoes except at Mwingama where An. funestus (99% 
mortality in 2011) and An. gambiae (98% mortality in 2012) showed clear 
susceptibility to etnofenprox. An. funestus was also fully susceptible to 
malathion in 2011 (98% and 99% mortalities) at Mwingama and Tsekera 
respectively. 
 
A comparison of resistance status of An. gambiae s.l and An. funestus s.l 
between the two years (2011 and 2012) against different insecticides was 
determined. There was a significant change in resistance pattern at 
Namila in An. funestus to lambda-cyhalothrin between 2011 and 2012 (X2 
= 6.011, P = 0.014). Anopheles funestus results from Namila showed no 
significant change to permethrin (91% mortality in 2011 and 87% 
mortality in 2012) (X2 = 0.433, P = 0.611). No significant change in 
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resistance was found to a pseudo-pyrethroid, etofenprox was shown at 
Namila between 2011 and 2012 (X2 = 0.147, P = 1.000). 
 
Similarly, there was no significant change in the percentage mortality for 
An. funestus to deltamethrin at Mwingama between 2011 (88% mortality) 
and 2012 (83% mortality) (X2 = 0.030, P = 1.000). Results show low cross 
resistance detected in both An. funestus s.l and An. gambiae s.l to 
carbamate and organophosphate insecticides.  
 
Very few tests were carried out on An. gambiae s.l from all the three sites. 
This was due to very low numbers of indoor resting An. gambiae being 
found and subsequently caught at the sites. Results for the tests on An. 
gambiae s.l from Namila showed a suspected level of resistance to 
lambda-cyhalothrin (84% mortality) in 2012. There was low resistance of 
An. gambiae s.l from Namila to malathion (94% mortality) in 2012 and 
bendiocarb (95% mortality) from Tsekera in 2012.  
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Table 5.5 WHO bioassay results for years 2011 and 2012 (n = total number of mosquitoes tested; nd = number dead; % M = 
Percentage-mortality). Note; The percentage control mortalities for all the bioassays were between 99% and 100%.
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5.3. Insecticide Quantification 
Every household with a window exit trap was sprayed with alpha-
cypermethrin.  This was not mandatory as household owners had a choice 
to accept or decline the spraying activity. Before the spray round started, 
nine pads were stuck randomly on the walls with 3 at high height, above 6 
foot, 3 at medium height, between 3 – 6 foot and 3 at low height, less than 
3 foot. At least two weeks after the spraying a pad from each height from 
each household was removed and tested by insecticide quantification kit 
(IQK) with reference to a colour chart (Fig 5.3). A total of 32 pads were 
screened for insecticide content.  Individual readings were taken to 
estimate variability of spray quality in each house. In order to estimate the 
average spray quality of each house, the individual reactions were pooled 
and the colour measured to provide a ‘pooled average’. Results of 
insecticide quantities and corresponding colorimetric images are listed in 
Table 5.5, Figures 5.2 – 5.9. 
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Table 5.6 Summary of results of wall pads and corresponding household attributes. Note: Empty entries mean there are no data present due to different 
reasons.  ½ Pad µg concentrations are those collected from immersion reagents in half the wall pad.  
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Fig 5.3 Standard alpha-cypermethrin serial dilutions. 
 
 Fig 5.4 Tsekera wall pads 
 
Fig 5.5 Mwingama wall pads 
 
Figure 5.3; Standard Alpha-cypermethrin serial dilutions made in methanol. 
Left to right: 16, 12, 8, 4, 2, 1, 0.5 and 0 mg/m2. Fig 5.4; Calorimetric results for 
Sekera wall pad samples 1414-1419. Fig 5.5; Results for Mwingama samples 
1420-1423. Insecticide was extracted from half a pad using acetone, then 5µl 
inoculated into the colorimetric reagents. 
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Fig 5.6 Mwingama wall pads 
 
Fig 5.7 Namila wall pads 
 
Fig 5.8 Namila wall pads 
 
Fig 5.6; Colorimetric results for Sekera wall pad samples 1424-27. Fig 5.7; 
Colorimetric results for Namila samples 1432-35. Fig 5.8 Colourmetric results 
for Namila samples 1436-39.  Insecticide extracted from half a pad using 
acetone, then 5µl inoculated into the colorimetric reagents. 
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5.4. Malaria and anaemia prevalence in the study site 
A continuous, rolling Malaria Indicator Survey (rMIS), was carried out from 
May 2010 to April 2011 covering a total of 637 young children of 6-59 
months old. This was developed into an expanded malaria indicator survey 
(eMIS), which was conducted from May 2011 to date, as a continuation to 
rMIS, but involving participants of all ages. A total of 1276 households 
were enrolled in which 637 (28%) were children 6-59 months old. 
 
The reported household coverage of ITN and IRS is shown across the entire 
catchment area (Figure 5.9). During the 12 months post IRS period (March 
2011 to March 2012), the reported average household IRS coverage for the 
50 villages was 63%  on average, declining sharply in April 2012 after expiry 
of the effective 12 month post-campaign period. Household Insecticide 
treated net coverage for the entire catchment area did not change 
significantly during the pre and post –IRS period 
 
The seasonal variation in P. falciparum parasitaemia prevalence across the 
entire 50 village catchment area before and after IRS is summarised in 
Figure 5.10 Results show parasitaemia prevalence declining from an 
average of 41% in the year before IRS, to 19% in the year following IRS, 
while moderate to severe anaemia (Hb< 8 g/dL) prevalence dropped to 
almost zero post IRS.  
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Figure 5.9: Intervention coverage by ITN and IRS for the 50 village 
catchment area from 2010 to 2012 
 
Figure 5.10:  parasite and anaemia prevalence, and rainfall for the 
overall study site from May 2010 to May 2012 
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6. DISCUSSION 
This work originated on the premise that direct monitoring and assessment 
of mosquito abundance and malaria transmission could measure the 
impact of vector control.  The study incorporated field, laboratory and 
insectary work to monitor the insecticide resistance status of An. gambiae 
and An. funestus; the predominant malaria vectors in Chikhwawa. The 
study also aimed to increase our knowledge of the malaria vectors in 
general to inform the scaling-up of indoor residual spraying in Malawi.  
While repeated rounds of IRS were planned, the National Malaria Control 
Programme implemented only a single IRS round during the study period. 
This provided an opportunity to assess the change in entomological 
indicators over time and duration of a standalone IRS round on top of 
other interventions.  
 
6.1. Main Findings 
6.1.1. Mosquito Abundance and Disease Transmission 
This study found a large heterogeneity in An. gambiae and An. funestus 
abundance between these nearby sentinel sites. Seventy four percent of 
the entire window exit trap collections were from Tsekera while only 18% 
was from Mwingama and 8% from Namila. The reasons for this 
heterogeneity in abundance, is likely multifactorial, linked to actual 
differences in breeding sites (some sites were close and the other further 
from the river) and/or factors that affected our measurement of 
abundance for instance the preferential choice of non-open eaves houses. 
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Tsekera village includes a higher number of water pools, this site was 
closest to the Shire River and with a lot of irrigation. Little irrigation was 
done at Namila and Mwingama, and Mwingama is an urban centre among 
the sentinel sites. Our quantification method of the water pools was based 
on visual inspection, scoring and counting informally at the time of the 
selection of suitable sites (not presented), rather than a standardized 
quantification technique to quantify breeding sites in order to properly 
explain the variations in mosquito abundance between households and 
villages on the basis of water pools.  While the use of a well defined 
methodology such as that described by Sattler et al [220-222]) would have 
improved our ability to define this association, the observed data on water 
sources does suggest a strong heterogeneity in breeding sites on a fine 
scale.  
Housing structure can be a main determinant of the number of mosquito’s 
present in a household.  Mwingama was the only urban site, located within 
Chikhwawa town centre, where the majority of houses are iron roofed and 
burnt bricked. Mosquito house entry has been shown to be reduced 
through simple changes in house design [223, 224] such as closing eaves, 
installing a ceiling, screening external doors and windows and a general 
improvement in quality of construction materials [224]. In these instances 
house entry rates are probably reduced by physically blocking or 
decreasing the number of holes through which a mosquito may gain access 
to a home. Houses can also be made less suitable for indoor resting 
mosquitoes by making them well lit, with few places for adult vectors to 
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rest, and this is often cited as one of the reasons for the decline in malaria 
in Europe [225]. 
One surprising observation from the study was that the numbers of both 
An. gambiae and An. funestus in the season November 2011/March 2012 
remained low in all the three sentinel sites despite the fact that IRS was 
not implemented that season. This is against a background of 
comparatively higher rainfall received in that season than the previous 
one. In Malawi the rains normally begin late October and this leads to a 
steady increase in mosquito population that peaks in January and then 
declines to low levels again by the end of the rain in April. This would, all 
else being equal, result in a higher abundance in the 2011/12 season than 
2010/11. More so, An. gambiae s.s thrives and predominates in humid 
conditions whilst An. funestus larvae thrive in grassy edges or shaded area 
of permanent and semi-permanent water bodies [55, 63], typical of 
Chikhwawa, and therefore we expected to observe increase in numbers of 
both species at this point. Obvious concerns of quality assurance as an 
attribute to such lower numbers collected over the period were ruled out 
by the fact that Culicines and flies were still collected in window exit traps 
suggesting that these were still being emptied on a daily basis as per 
agreed study procedures, this was confirmed at the time of unannounced 
spot check visits.   
There was a drop An. funestus sporozoite rate for Mwingama, Namila, and 
Tsekera   from 2%, 4% and 8% respectively to 0 between February and July 
2011 post IRS. This is technically the number of Anopheles infectious with 
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sporozoites divided by the total number of An. tested for sporozoites. This 
result is in agreement with trends in parasitaemia prevalence obtained in 
under 5yrs old children within the 50 village area which also dropped from 
about 55% to 12% from April to August 2011 (Fig. 5.1). The drop in 
parasitaemia could be explained by an increase in multifaceted 
intervention coverage by ITN and IRS for the 50 village catchment area 
from 2010 to 2012 in addition to adoption of policies that is promoting 
confirmed malaria diagnosis using malaria microscopy and / or rapid 
diagnostic tests (RDTs) from 2012. This could reduce parasite 
recrudescence. 
6.1.2. Insecticide Resistance 
A study in Chikhwawa district in 2007 detected no resistance to 
pyrethroids in An. gambiae, An. funestus and An. quadrianulatus [211]. 
However, we report here just years later the results of WHO bioassays that 
detected low (suspected) levels of insecticide resistance in both An. 
gambiae and An. funestus to the pyrethroids deltramethrin, lambda-
cyhalothrin and permethrin. This suggests a selection for insecticide 
resistance in the last 4-5 years. The levels of pyrethroid resistance found 
here are in agreement with the results found in a 2012 study where the 
authors showed elevated levels of p450s are associated with the 
pyrethroid resistance in Chikhwawa An. funestus [157].  
This same resistance pattern in An. funestus populations has been 
reported in southern [152, 226, 227] and northern Mozambique [228]; 
close to the Malawi border. More recently evidence of pyrethroid 
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resistance in An. funestus from Likoma Island, on Lake Malawi has also 
been reported [156]. Overall this suggests that this resistance mechanism 
has spread to Malawi [53]. It is also feasible however, that the insecticide 
resistance has been selected de novo in Chikhwawa. This could be the 
result of insecticide use in agriculture, as seen elsewhere [129, 229] 
together with the gene flow in malaria vectors [230, 231]. Vector species 
can potentially be exposed to agricultural insecticides through residual run-
off into vector breeding sites. In Malawi the range of insecticides used for 
agricultural activities has resurged recently with the resultant potential 
increase in exposure of mosquito populations to a broad range of 
insecticides. There has been a history of extensive application of 
insecticides in agriculture in the Chikhwawa area through the Malawi 
government farmers input subsidy programme (FISP), where insecticide, 
especially pyrethroids, have been heavily disbursed to the farmers at no 
cost or subsidized rate since 2005 as reported by the Shire Valley ADD 
personnel (Personal communication). Recently, selection pressure from 
agricultural use has been implicated in the development of resistance in 
An. gambiae in Burkina Faso [129]. 
More recently the utilization of insecticides for vector control may have 
contributed to either de novo resistance or an increased selection pressure 
for spread of insecticide resistance. The NMCP LLIN distribution 
programme started in 2007 delivering LLINs to pregnant women during 
ANC visits and to women who attended EPI clinics with their children. This 
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has resulted in a household coverage of LLINs of nearly 60% in Chikhwawa 
(See figure 5.9) [41]. 
 
The selection of insecticide resistance has great potential to compromise 
any insecticide-based malaria vector control programme [232, 233]. The 
resistance reported here in An. funestus and An. gambiae, Malawi’s major 
malaria vectors, is of major concern, as the current vector control policy is 
insecticide based, and uses pyrethroids for both IRS and ITNs.  
With the advent of more sophisticated biochemical and molecular assays 
for resistance detection, it is now feasible to accurately analyse large 
numbers of insects for a range of insecticide resistance genes and monitor 
their changes over time [189, 234, 235]. Biochemical mechanisms; AChE, 
GST, general esterase activity and monooxygenase (p450) were not  
carried out in this study due to an inadequate cold chain to get the samples 
to a suitable laboratory. However, the use of novel techniques, including 
microarray, allow the detection of resistance mechanisms without the 
need for a cold chain [236, 237].  
With the recent real-life example of how the same resistance mechanism 
observed here in An. funestus can be associated with the failure of a control 
programme in South Africa, the use of pyrethroid insecticides for IRS at this 
stage in Malawi is not evidence-based, and should be discouraged. The 
South African example of resistance in An. funestus with this mechanism is 
the only documented vector control programme failure due to insecticide 
resistance.  In South Africa An. funestus has successfully been controlled by 
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IRS with DDT for over 50 years [151]. From the bioassay results, carbamates 
and organophosphates seem to be more effective at both An. gambiae and 
An. funestus than the pyrethroids. It is therefore important to have fuller 
understanding of all the resistance mechanisms in all vectors and based on 
that a good insecticide choice and resistance management strategy should 
be implemented. 
6.1.3. Insecticide Quantification and Quality Assurance 
A successful insecticide based vector control programme is enhanced by 
strong quality control procedures. Currently the recommended way for 
monitoring residual efficacy of an insecticide on a surface, post IRS, is via 
the WHO cone assay [238]. This is logistically challenging, as it requires the 
maintenance of mosquito colonies and transportation of colonies to the 
field. As such these assays are rarely done in an operational setting. Under 
the initiative of the Innovative Vector Control Consortium (IVCC) [239], 
new tools were developed to more easily carry out quality assurance. 
The colorimetric results on wall pads show low-level insecticides 
(<25mg/m2) in all the three villages. The colorimetric assays rely on the 
chemical detection of cyanide released by alkaline hydrolysis [240]. This 
suggests that inadequate insecticide concentration was applied to the 
surface. WHO currently recommends a concentration >20mg/m2 [238].The 
insecticide used by the NMCP for this round of IRS was Morkid with the 
active ingredient of lambda-cyhalothrin. The formulation is well below the 
concentration recommended by WHO and is likely not to adhere to the 
surface of house structures found in Chikhwawa. This would account in 
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part for the low detection of active ingredient. However, this detection of 
low-level active ingredient may also have been compounded by poor 
quality of the IRS round and the length of time (12months) that the wall 
pads were stored at -200C before analysis. According to Paine el al 
(unpublished) colorimetric analysis of the wall pads is ideally to be done 
one month post spraying.  
The major strength of this wall pad work, however, is that it is technically 
feasible to monitor quickly the quality of individual spray operators and the 
residual efficacy of the insecticide on a surface. The IQK are a novel tool for 
monitoring and evaluation of insecticides that have been sprayed on a 
surface. As the kits are developed for the commercial market they will be 
looking to record, no spray, under sprayed, correct spray and over spray.  
There are a number of confounding factors in this study that will have 
influenced the outcome not least those discussed. Quality of the actual IRS 
operator needs consideration. Actual IRS application was not supervised so 
we have no knowledge if all pads were sprayed or not. 
6.2. Impact of IRS and Study Limitations 
Based on this entomological assessment, it is not possible to show whether 
the Chikhwawa IRS was successful or had a direct impact on both mosquito 
abundance and reduction in malaria burden. Contrary to a similar 
assessment work in Bioko, Equatorial Guinea [46, 160] where  continuous 
entomological monitoring of the IRS showed successful control of all three 
vectors that were responsible for malaria transmission before the start of 
the intervention, the Malawi scenario had a lot of logistical and 
113 
programmatic limitations rendering our assessment quite unreliable. The 
collection work started in October 2010 when IRS was planned to 
commence, however it was delayed until the following year in 
February/March. This is the peak period for both the malaria vectors in 
Chikhwawa and the IRS therefore coincided with the natural period of 
mosquito decline toward the end of rainy season in March/April. This 
natural fall coinciding with IRS implementation made it difficult to attribute 
the decline as a direct impact of IRS. 
In our continuous monitoring work, we did not have 2009/10 comparative 
baseline mosquito abundance data. This should have assisted in comparing 
trends in mosquito abundance in the wake of the delayed IRS. The only 
comparison therefore was to compare the periods between the years 2011 
and 2012. Unfortunately, IRS was not implemented in the year 2011/12 
which meant we had no data to compare with, as such our comparisons 
were only for  the 5 month dry period pre-IRS (October 2010 to February 
2011) and 5 months post IRS (March to July 2011). 
 
This section highlights and discusses the limitations of this study. Where 
possible, justifications have been made on the steps taken and suggestions 
on how the standard procedures should have been improved.  
The study lacked a contemporous control village. Ideally a control village, 
or villages, with similar ecology and disease burden would have been ideal 
for this study. This would have made good comparison on the numbers of 
mosquitoes collected and the impact of IRS on local malaria risk pre and 
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post intervention. However, this was not feasible as NMCP aimed for 
universal coverage in the district and region with IRS. An alternative 
control well outside the Shire valley region would have had a different 
ecology, vector species distribution and disease pattern. It was felt that 
this would offer no comparison and just add logistical and cost 
implications. 
The selection criteria of households within the selected sentinel sites for 
species abundance could have been improved.  There was need for more 
stringent setting of pre-selection criteria. Household selection was based 
on firstly, how permanent it would be before being demolished and 
rebuilt, as is the case with many temporally dwellings within the area. 
Secondly, a choice was set for household that had a separate kitchen from 
the bedroom or main house so that kitchen smoke should not darken the 
white window trap nor confound with mosquito abundance and migration 
within the house. This decision was based on anecdotal evidence that 
suggested that the smoke created by burning biomass fuels inside houses 
may repel host-seeking mosquitoes [241], although an in-depth literature 
review found little evidence that smoke from fires led to a corresponding 
reduction in malaria [223]. This criterion created a bias in the selection and 
it would have been better if we had randomly picked any house within the 
quadrant of interest regardless of any other physical factors. Finally, 
household selection was based on consideration of houses with minimal 
open eaves to allow for easy mounting of the exit window trap. Usually 
houses with large open eaves are temporary and easily abandoned and 
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therefore not ideal for the collection process. While the selection of closed 
eaves may be seen as a limitation, because these houses may not have 
been representative over the overall housing structure in the village, this 
did help the accurate collection of mosquito abundance trend over time as 
there would be less variation attributed to the entry and exit through the 
eaves. 
The third limitation to the study was that we only made a single 
assessment of IRS spray round pre and post spray. Ideally it would have 
been worthwhile to cover at least two consecutive spray rounds to 
ascertain whether the mosquito abundance trend is really as a result of the 
IRS intervention or other confounding factors.  This was not possible 
because the second round of IRS was delayed. Initially, the second IRS 
round was planned to be implemented from October 2011 but it never 
happened until the following season 2012/2013. This therefore meant we 
had a single data set to compare with i.e. pre and post IRS of 2010/2012. 
However, because the study covered two rainy seasons of 2010/11 and 
that of 2011/12, we managed to make a comparison of the mosquito 
abundances between these two consecutive seasons. 
Timing of the spray round was another limitation. Ideally IRS is supposed to 
be conducted at the onset of the rainy season i.e. October for Chikhwawa, 
however the first IRS was delayed to the following year until February right 
within the rainy season. The delayed IRS may have affected the overall 
community level IRS coverage negatively, as there were reports of 
households declining participation because it required them to put their 
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furniture outside in the rain. Similarly, this would also compromise the 
natural trends of mosquito abundance, as it occurred at time of declining 
abundance, and it is impossible to attribute the decline to the IRS for this 
reason. 
The quality assurance of data collection conducted independently by 
household owner may raise concerns of bias in this study. However, we 
attempted to address this by thorough training on mosquito collection to 
every household owner undertaking the daily mosquito collections. Safety 
information on handling of isopropanol, and other collection material as 
well as practical illustration of the entire mosquito collection and recoding 
process was performed at every household and the household owners 
demonstrated independence in doing the entire process. Routine refresher 
trainings and general update meetings were facilitated at every monthly 
visit to enhance quality of the collection and identify and resolve potential 
problems encountered by the household owners in the course of the 
collection. Data from Culex species or any flies collected in the window exit 
traps assisted in confirming that collection was indeed taking place. 
Furthermore, routine and surprise spot check visits were conducted for 
quality control purposes to check whether the household owner was 
collecting the mosquitoes and documenting the collections as per study 
operating procedures. 
On WHO bioassays performed in the study, a notable limitation was low 
numbers of mosquitoes that were sometimes subjected for the 
experiment. Ideally, controlled triplicates of at least 25 mosquitoes per 
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bottle are recommended for the bioassays [219]. However depending on 
the seasonality and availability of the adult indoor resting mosquitoes, as 
was the case, it was difficult to meet the prescribed numbers of the F1 
generation at goal. This then meant that sometimes we were either 
working with fewer mosquitoes or sometimes completely redoing 
experiments at a later time.  Our findings were however consistent with 
those from other groups assessing insecticide resistance in the same area 
[52] signifying the reproducibility as well as the evidence of pyrethroid 
resistance in the Anopheles spp. 
As regards comparable clinical data for the study, a notable limitation was 
that parastiaemia data was collected from 50 villages in the area, and the 
data from the 3 villages involved in the entomological study was low. A 
direct comparison between parasitaemia and entomology in the 3 villages 
was not possible, due to low sampling points from the MIS survey [213] 
However, the likely trend in parasitaemia presented, likely reflects the 
entomological findings.  
Overall, despite these limitations, the conducted study adds valuable 
information on the changes in abundance, insecticide resistance profile 
and insecticide quantification as an easy way to measure surface 
concentrations of insecticide to ensure good quality spraying. The study 
results on resistance is consistent with findings from other studies within 
the same region [52, 157, 211] and neighbouring countries and describe a 
low-cost approach that adds considerable information in a setting where a 
randomized controlled design was no longer an option.  
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The impact of IRS on mosquito abundance and malaria burden is not clear 
as partly suggested by the pre-post data comparison because of among 
others the limitations described above. However, the low numbers of 
mosquitoes in the succeeding spraying season (albeit not implemented) 
suggests that 2010/11 IRS might have crashed the mosquito population 
and that the breeding numbers for the succeeding seasons were still lower 
to create an upsurge in the numbers  
6.3. Conclusion 
In this high transmission area, continuous entomological surveillance 
proved low cost complementary monitoring and evaluation tool to assess 
the impact of IRS. Essential to the success of the IRS campaign is the 
implementation of strong quality control procedures that facilitate the 
assessment of programmatic effectiveness in a simple and manner. It is 
therefore important to incorporate entomological and burden monitoring 
and evaluation assessments to accurately monitor short term impact on 
vector control efforts.  
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7. APPENDIX 1 
WRITTEN INFORMED CONSENT FORM (English) 
 
Vector Assessment 
 
Informed Consent Form for: Household owner 
 
Title of Project 
ACTia - Vector Population Monitoring Tool (VPMT) 
 
Part 1: Consent Explanation 
[To be read and questions answered in the volunteer’s local language]. 
 
Participation Information:  
This project is part of ACTia (safety and effectiveness of combination 
therapies with repeated treatments for uncomplicated P. falciparum 
malaria) currently operating in this area. This entomological 
component is being carried out to better correlate the distribution and 
species abundance of malaria mosquitoes toward safety and 
effectiveness of combination therapies with repeated treatments and 
bring a better service to the community as a whole.  
 
We would like to seek permission to have your house fitted with a 
window trap to collect mosquitoes.  
 
It is very important that you understand the following general 
principles that apply to all participants in this project: 
 
1) Permission to enter your house is entirely voluntary.  
2) Persons may withdraw from participation in this study at any 
time.  
3) Refusal of permission to collect mosquitoes from your house 
will involve no penalty 
[After you read the explanation, please feel free to ask any question 
that will help you to understand more clearly the nature of the study]. 
 
Type of Information/ Data.  
1. Mosquito abundance. 
2. Types of mosquitoes found in the community. 
3. The number of mosquitoes carrying malaria infections 
 
House selection 
Six houses in the village will be selected and have window traps fitted.  
 
The house owner will be asked to remove the mosquitoes from the 
trap every day and empty them into specially prepared tubes. 
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Procedures to be followed 
No humans will be involved in mosquito collection procedures. Once 
permission is given by the owner of the selected house, a window trap 
will be fitted to one of the windows by the project team for routine 
mosquito collection. 
[The window trap will not interfere with everyday household duties] 
 
Every day the house owner will inspect the trap, remove mosquitoes 
with an aspirator and store them in ready prepared tubes for later 
analysis. 
 
At the end of the month the project team will collect the filled tubes for 
analysis.  
 
Duration of the study 
This activity may take up to 3 years but time frame is dependent on the 
ACTia’s major work plan. 
 
Benefits 
To compensate for the time loss in collecting mosquitoes, the house 
owner will be compensated $10 (or its equivalent in Malawi Kwacha) 
per month. 
 
Assurance of confidentiality:  
No information on private life will be recorded or discussed with 
anyone. You will receive a copy of this consent form. 
Questions 
[If there is any section of this consent explanation sheet that you do 
not understand, you are welcome to ask the investigators before 
signing for explanation]. 
Signatures 
 
Name of Householder: 
|____________________________________________| 
 
Signature or: |__________________________| 
 
 
Thumbprint (if cannot write):  
 
 
 
Date:|_____/______/______| 
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Part 2: Certificate of Consent 
I, _________________________________, having understood the 
explanation of the project given do give permission to fit my house 
with a window trap to collect mosquitoes for the project. The nature, 
duration, purpose and methods by which the project will be  
conducted; and  the inconveniences and hazards which may be 
expected have been explained to me in full by 
________________________________, and are set forth in the 
Informed Consent Explanation, which I have signed (and received a 
copy). I have been given an opportunity to ask questions concerning 
this investigational project, and any such questions have been 
answered to my full and complete satisfaction. Should any further 
questions arise, I may contact Dr Michael Coleman or Benjamin Nyoni 
at 099 5825 417. 
 
I understand that I may at any time during the course of this study 
refuse permission to collect mosquitoes from my house prejudice. 
 
Name of Householder: |_________________________| 
Signature: |______________________| 
 
Thumbprint (if cannot write): 
 
Date: |______/______/______ 
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